Role of WRB protein in cardiac function by Rivera Monroy, Jhon Erick
 
 








Dissertation for the award of the degree 
“Doctor of Philosophy”  
Division of Mathematics and Natural Sciences 
of the Georg-August-Universität Göttingen 
within the Göttingen Graduate School for Neurosciences, Biophysics and 
Molecular Biosciences (GGNB) 









Members of the Thesis Committee and Examination Board: 
 
 
Supervisor, reviewer  Prof. Dr. Blanche Schwappach 
Department of Molecular Biology, 
University Medical Center Göttingen 
Max Planck Institute for Biophysical 
Chemistry 
 
Thesis committee, reviewer: Prof. Dr. Michael Meinecke 
Department of Biochemistry II, 
University of Göttingen 
European Neuroscience Institute 
 
Thesis committee, reviewer: Dr. Hans Dieter Schmitt 
Max Planck Institute for Biophysical 
Chemistry 
 
Reviewer:    Prof. Dr. Michael Thumm 
     Department of Cellular biochemistry 
University Medical Center Göttingen 
      
Reviewer:    Prof. Dr. Ralph Kehlenbach 
Department of Molecular Biology, 
University Medical Center Göttingen 
 
Reviewer:    Prof. Dr. Ivo Feussner 
     Department of Plant biochemistry 
     University of Göttingen 
 






I hereby declare that I prepared the PhD thesis “Role of WRB protein in 



























Adam and Eve were black? 
The human adventure in the world began in Africa. From there, our ancestors set out to 
conquer the planet. Many paths led them to many destinies, and the sun took care of 
handing out colors from the palette. 
Now the rainbow of the earth is more colorful than the rainbow of the sky. But we are all 
emigrants from Africa. Even the whitest of whites comes from Africa. Maybe we refuse to 
acknowledge our common origins because racism causes amnesia, or because we find it 
unbelievable that in those days long past the entire world was our kingdom, an immense 
map without borders, and our legs were the only passport required. 
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The mammalian TRC40 system is a conserved pathway responsible for 
the post-translational targeting of tail-anchored proteins, which are 
characterized by a single transmembrane domain at the C-terminus and 
an N-terminus that faces the cytosol. The cytosolic ATPase TRC40, Get3 
in yeast, binds newly synthesized TA proteins and targets them to the ER 
where they are inserted via a membrane receptor formed by WRB and 
CAML, functionally equivalent to yeast Get1 and Get2. This 
heteromultimeric membrane protein complex works as a docking site for 
TRC40 and "insertase" for TA proteins. Although several molecular 
aspects of the pathway have been elucidated in recent years, it is poorly 
understood how the pathway is integrated into the cellular proteostasis 
network in vivo. In order to gain insight into this question, the fate of 
several TA proteins (Sec61β, syntaxins 5, 6 and 8 and emerin) was 
evaluated in a heart-specific, inducible knockout of WRB mouse model. 
Our analysis showed that endogenous syntaxin 5 and emerin are reduced 
upon WRB depletion. On the one hand, we observed that syntaxin 5 is 
degraded by autophagy upon disruption of the TRC40 pathway, 
constituting a novel mechanism for the clearance of TA proteins. On the 
other hand, our results confirm that emerin, a clinically relevant TA protein 
of the nuclear envelope, depends on the TRC40 pathway for its insertion 
into the ER and targeting to its final destination. Our results suggest the 
TRC40 pathway does not only contribute to insertion fidelity of its clients 
but also to their overall stability. 
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Integral Membrane Protein    IMP 
Transmembrane Domain    TMD 
Tail-Anchored protein    TA protein 
Endoplasmic Reticulum    ER 
Signal Recognition Particle    SRP 
Transmembrane Recognition  
Complex subunit of 40 kDa    TRC40 
Guided Entry of Tail-anchored proteins 3 Get 
Arsenical pump-driving ATPase    ArsA 
Tryptophan-rich basic protein   WRB 
congenital heart disease protein 5   CHD5 
Small glutamine-rich tetratricopeptide 
repeat-containing protein alpha   SGTA 
Short Secretory Protein Precursor  SSPP 
Short Secretory Protein    SSP  
Glycosylphosphatidylinositols protein  GPI protein 
Guanine-nucleotide Exchange Factor  GEF 
G Protein-Couple Receptor   GPCR 
Mitogen-Activated Protein Kinase   MAPK 
Apoptosis Inducing Factor     AIF 
SRP-independent targeting pathway  SND pathway 
Ring Finger Protein 126    RNF126 
Cysteine-String Protein     CSP 
Mislocalized Protein     MLP 
Ubiquitin-Like domain     Ubl domain 
Emerin      EMD 
Emery-Dreifuss Muscular Dystrophy  EDMD 
Syntaxin 5      Stx5 
Syntaxin 6      Stx6 
Syntaxin 8      Stx8  
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Introduction 
Biogenesis of integral membrane proteins of the 
secretory pathway 
All biological membranes contain integral membrane proteins (IMP) that 
are structurally diverse and collectively constitute 20-30% of the proteome 
of every organism. This subgroup of proteins perform an enormous range 
of cellular activities including communication across the membrane, 
transport of substances, membrane morphogenesis, among many others 
(Hegde and Keenan, 2011; Wallin and Heijne, 1998). 
 
The common feature of IMPs is the presence of at least one hydrophobic 
transmembrane domain (TMD). TMDs allow protein anchoring thanks to 




Figure 1. Classification of Integral membrane protein topology. 
 
In contrast to soluble proteins that are synthetized in the hydrophilic 























IMP biogenesis. Several pathways for the biogenesis of membrane 
proteins have evolved to protect the precursor protein from aggregation, 
allowing at the same time the correct topological orientation of the protein 
into the membrane. 
 
IMPs are targeted to the membranes of mitochondria, peroxisomes, 
chloroplasts and the endoplasmic reticulum (ER) (Chacinska et al., 2009; 
Garg and Gould, 2016; Giannopoulou et al., 2016; Hegde and Keenan, 
2011). From the ER IMPs can reach all other cellular membranes 
connected to the secretory pathways, and also to the inner and outer 
nuclear membranes. 
Pathways for the insertion of ER membrane 
proteins 
Considering the central role of the ER membrane in protein biogenesis as 
the place of insertion of IMPs of secretory pathway compartments and the 
nuclear membrane, the pathways involved in membrane protein insertion 
at the ER have being extensively studied in the last 4 decades.  
 
These pathways can be classified in co-translational and post-translational 
pathways (Fig. 2). In the co-translational pathway, the synthesis of the 
protein occurs in a nearly complete way on the ER membrane, synthesis 
and insertion occurring as a coupled process. In contrast, the membrane 
protein insertion via a post-translational pathway occurs after the protein is 
synthetized and released into the cytosol. To date, two different types of 
ER-targeting sequences have been characterized in eukaryotes: the 
cleavable N-terminal signal sequence and the TMDs that act at the same 
time as membrane anchors (Ast et al., 2013). 
 
The first and most studied co-translational pathway identified is the Signal 
Recognition Particle (SRP) pathway (Blobel and Dobberstein, 1975a; 
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Blobel and Dobberstein, 1975b), a pathway that relies on a complex of the 
same name and that is conserved in all three domains of life (Pool, 2005). 
The SRP pathway is involved in ER membrane insertion of single- and 
multi-spanning proteins and also, in the translocation of soluble 
polypeptides from the cytosol to the ER lumen.  
 
Figure 2. ER targeting pathways: Co-translational (SRP), post-
translational GET pathway and the recently discovered SND targeting 
components. See text below for the pertinent references. 
 
SRP recognizes a hydrophobic N-terminal signal sequence on the nascent 
polypeptide emerging from the exit tunnel of a translating ribosome. Once 
bound, SRP is also able to pause the translation until the SRP-ribosome 
macrocomplex is recruited to the Sec61 translocon at the ER membrane 
via the SRP receptor, where translation is resumed (Grudnik et al., 2009). 
 
Although many ER IMPs are inserted co-translationally, several studies 
have shown that a subset of membrane proteins are inserted in a post-
translational manner (Kutay et al., 1993). This subset of proteins, known 


















characterized by the absence of an N-terminal signal peptide and a single 
TMD towards the C-terminus (Kutay et al., 1993). 
 
TA proteins are present in all three domains of life; in eukaryotes they 
represent 3 to 5% of all IMPs and are located in all cellular membranes. 
TA proteins exert functions related to membrane biogenesis, apoptosis 
(e.g., Bcl-2, Bcl-XL, Bax), intracellular trafficking (e.g., most of the SNARE 
proteins involved in vesicular fusion are TA proteins), protein translocation 
(e.g. Sec61β and Sec61γ), transcription regulation (emerin), protein 
maturation, degradation, organelle structure, and lipid homeostasis, 
among others (Hegde and Keenan, 2011; Jonikas et al., 2009; Kalbfleisch 
et al., 2007; Schuldiner et al., 2008; Shao and Hegde, 2011; 
Wereszczynski and McCammon, 2012). 
 
The TMD of TA proteins provides a targeting signal for the delivery of the 
newly synthesized TA protein into the target membrane (i.e. ER, 
peroxisomes, outer mitochondrial membrane, and the plastid outer 
envelope) and acts as an anchor that retains the TA protein in the 
membrane once the integration has taken place (Borgese and Fasana, 
2011; Rabu et al., 2009). Recent work has suggested that more than one 
post-translational pathway operates in ER targeting of TA proteins. In vitro 
studies have shown the existence of (i) an unassisted insertion pathway 
by which proteins with moderate hydrophobic TMDs spontaneously 
integrate into the membrane (Colombo et al., 2009) and (ii) assisted 
chaperone-mediated, energy-requiring pathways, by which most ER-
targeted TA proteins reach their destination (Borgese and Fasana, 2011). 
So far four post-translational assisted pathways have been described: one 
mediated by SRP itself (Abell et al., 2004), one by the Hsc70/Hsp40 
chaperone complex (Abell et al., 2007), one mediated by the recently 
described SND components (Aviram et al., 2016), and one by the 
Transmembrane Recognition Complex subunit of 40 kDa (TRC40) in 
mammals or by Guided Entry of Tail-anchored proteins 3 (Get3) in yeast 
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(Favaloro et al., 2008; Schuldiner et al., 2008; Stefanovic and Hegde, 
2007). Among them, The TRC40/Get3 is currently thought to be the 
preferential insertion pathway for most of the TA proteins. 
The TRC40/Get3 pathway 
Mammalian TRC40 (also known as Asna1) and its yeast counterpart Get3 
(Arr4) are cytosolic P-loop ATPase homodimers that bind the TMD of TA 
proteins and deliver them to the ER membrane (Favaloro et al., 2008; 
Schuldiner et al., 2008; Stefanovic and Hegde, 2007). The GET3/ASNA1 
genes are homologous to the arsenical pump-driving ATPase (ArsA), 
thought to function as a regulatory component of the bacterial arsenic 
export pump (Boskovic et al., 1996; Karkaria et al., 1990; Kaur and Rosen, 
1992; Rosen et al., 1988). 
 
Genetic and biochemical approaches have shown that several proteins 
interact with Get3 during the biogenesis of TA proteins as part of the yeast 
GET pathway (Auld et al., 2006; Jonikas et al., 2009; Schuldiner et al., 
2008), most of them are conserved from yeast to mammals (Table 1). 
Get1 and Get2 are membrane proteins that associate in a hetero-
oligomeric complex and recruit Get3 to the ER membrane (Jonikas et al., 
2009; Schuldiner et al., 2008), whereas Get4 and Get5 interact with the 
Sgt2 protein in the capture of newly synthesized TA proteins at the 
ribosome and their delivery to Get3 (Battle et al., 2010; Chang et al., 2010; 
Jonikas et al., 2009; Simpson et al., 2010). 
 
Structural studies have shown that the interaction of Sgt2 and the Get4-
Get5 complex is mediated by the ubiquitin-like domain of Get5 (Chartron 
et al., 2012; Wang et al., 2010). The C-terminal region of Sgt2 is thought 
to bind to the TMD of the nascent TA protein right after it emerges from 
the ribosome, thus bringing the TA proteins into the vicinity of the Get4-
Get5 complex (Wang et al., 2010). The Sgt2-Get4-Get5 complex recruits 
ATP-bound Get3 via the interaction between Get4 and Get3, inhibiting the 
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ATPase activity of Get3. This facilitates the transfer of the TA protein from 
Sgt2 to Get3, which also binds the TA protein TMD (Chang et al., 2012; 
Chartron et al., 2010). Once Get3 is loaded with the TA protein, the 
ATPase activity of Get3 is enhanced (Rome et al., 2013), leading to the 
formation of an ADP-bound Get3–TA protein complex, which is competent 
for ER membrane targeting.  
 
This targeting-competent complex is initially recruited to the membrane 
through an interaction of Get3 with a negatively charged region in the N-
terminal domain of Get2 (Mariappan et al., 2011; Stefer et al., 2011). 
Subsequently, the cytosolic coiled-coil domain of Get1 interacts with Get3 
to drive TA protein release concomitantly with ADP release.  
 
The final membrane integration step has been a matter of extensive 
discussion since the receptor was described. Using a biochemical 
reconstitution approach, it was recently demonstrated that the Get1-Get2 
receptor plays a direct role as an insertase during the insertion of TA 
proteins into the ER membrane (Wang et al., 2014). According to this 
report, the TMDs of Get1 and Get2 interact with the TMD of the TA protein 
close to the cytosolic surface of the ER bilayer and collaborate with the 
cytosolic domains of the Get1-Get2 receptor to release the TA substrate 
from the open conformation of Get3, thus allowing integration of the TA 
protein TMD into the membrane. 
 
Like in yeast, the capture of TA proteins in mammals by ATP-bound 
TRC40 is facilitated by an upstream pretargeting complex (Fig. 3) thought 
to associate with the ribosome. This complex is formed by BAG6 (Bat3), 
TRC35, and UBL4A; where the latter two proteins are homologs of Get4 
and Get5, respectively (Leznicki et al., 2010; Mariappan et al., 2010). 
Although mammalian BAG6 and yeast Sgt2 are not related, it is 
noteworthy that BAG6 interacts with SGTA, the mammalian homologue of 
Sgt2 (Winnefeld et al., 2006). 
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homologue Function in TA-protein insertion References 
TRC40 
(Asna1) Get3/Arr4 
P-loop ATPase. As a dimer, TRC40 shields the TA-
protein TMD in the cytosol and delivers it from the 
pretargeting complex to the ER membrane. 
(Favaloro et al., 2008; Mateja et al., 2015; 
Schuldiner et al., 2008; Stefanovic and 
Hegde, 2007) 
BAG6 (BAT3) 
(Scythe) Not present 
Ubiquitin-like domain, BAG-domain containing 
protein. Major component of the pretargeting 
complex. Along with UBL4A and TRC35, brings 
SGTA and TRC40 chaperones together. 
(Leznicki et al., 2010; Mariappan et al., 
2010) 
UBL4A Get5/Mdy2 Ubl domain-containing protein. Binds SGTA directly in the pretargeting complex.  
(Jonikas et al., 2009; Mariappan et al., 
2010) 
TRC35 Get4 Binds TRC40 directly in the pretargeting complex.  (Jonikas et al., 2009; Mariappan et al., 2010) 
SGTA SGT2 
Small glutamine-rich tetratricopeptide repeat peptide-
containing chaperone that is part of the pretargeting 
complex. SGTA shields TA-protein’s TMD once 
released from the ribosome, acting upstream to 
TRC40. 
(Chang et al., 2010) 
WRB (CHD5) Get1 Tryptophan Rich Basic protein. Multispanning protein of the ER. It is part of the TRC40 receptor. (Vilardi et al., 2011; Vilardi et al., 2014) 
CAML Get2* Calcium modulating cyclophilin ligand. It is the second component of the TRC40 receptor. (Yamamoto and Sakisaka, 2012) 




Figure 3. Roles of the mammalian TRC40 ATPase. TRC40 can target 
substrates of different nature to the ER membrane: 1. Post-translational 
insertion of TA proteins into the membrane. 2. Post-translational 
translocation of short secretory proteins SSP. SS: Signal Sequence, 
SSPP: Short secretory protein precursor. As indicated by the dashed line 
current insight into the mechanism of SSPP targeting via TRC40 is limited. 
 
It was demonstrated that the ER proteins WRB (homologue of Get1) and 
CAML (functional equivalent of Get2), form the receptor complex for TA 
protein insertion in mammals (Vilardi et al., 2011; Vilardi et al., 2014; 
Yamamoto and Sakisaka, 2012). Taking into account recent studies that 
suggest that Get1/Get2 receptor work as an insertase (Wang et al., 2014) 
it seems plausible to hypothesize that WRB and CAML fulfill the same 






















Figure 4. Proposed mechanism of the WRB/CAML receptor as an 
insertase.  
Alternative roles of the TRC40/Get3 ATPases 
Apart from the well-known ATP-dependent targeting of TA proteins to the 
ER membrane, TRC40 is also involved in the translocation of short 
secretory peptides across the ER bilayer (Johnson et al., 2012) and 
potentially in GPI-anchored proteins biogenesis in an SRP-independent 
manner (Ast et al., 2013). 
 
In-vitro studies carried out by Johnson et al. identified two human short 
secretory protein precursors, apelin and statherin, as bona fide substrates 
of TRC40 (Johnson et al., 2012). Both proteins interact with TRC40 and 
use this protein for their delivery and post-translational translocation 
across the ER membrane in a mechanism that appeared to be Sec61 
translocon-dependent. Moreover, the cytosolic coiled-coil fragment of 
WRB, inhibits such translocation in vitro, suggesting the TRC40 receptor 
might be also involved during substrate translocation.  
 
Combining hydrophathy-based analysis and high-throughput microscopy 
Ast et al. (2013) evaluated the prevalence SRP-independent pathway(s) in 
the translocation of secretory proteins in yeast. This screen revealed that a 
subset of GPI-anchored proteins containing a hydrophobic C-terminal 
targeting element required for their eventual modification with a glycan-






direct as Get3 interacted with the GPI-anchored HA-Gas1; furthermore, 
this dependence correlated with a high hydrophobicity of the C-terminus in 
the GPI-anchored proteins. Such a correlation has also been observed in 
the targeting of TA proteins in vitro (Favaloro et al., 2010; Jonikas et al., 
2009; Leznicki et al., 2010; Schuldiner et al., 2008; Stefanovic and Hegde, 
2007). 
 
Recently, our lab has described novel functions of Get3 as a holdase 
chaperone upon stress conditions, such as energy depletion or oxidative 
stress (Powis et al., 2013b; Voth et al., 2014). Powis et al. (2013) 
observed that Get3 rapidly relocalizes to foci following glucose starvation. 
These foci resulted to be protein-rich, membrane and ribosome-free 
deposition sites where aggregated TA proteins (i.e. the Sed5 SNARE 
protein) and other chaperones and disaggregases (i.e. Hsp42, Hsp104, 
Sis1 and Ssa2) were also found together with Get3. The localization of 
Get3 in foci was not observed in the knockout of the cytosolic components 
Get4 and Get5; in contrast, in a get1/get2 strain (receptor KO) foci were 
observed even without exposing the cells to stress. 
 
In-vitro studies clearly showed that Get3 acts as a chaperone holdase 
when ATP is not available. Moreover, addition of adenosine nucleotides 
strongly inhibited this function (Voth et al., 2014). The D57E Get3 mutant, 
a mutant protein with an impaired ATP-hydrolysis activity but preserved 
TA protein binding, accumulates in foci irrespective of glucose availability 
which is consistent with the observed change of localization of the protein 
when cells are glucose-starved (Powis et al., 2013a).  
 
Voth et al. (2014) demonstrated that Get3 turns into an ATP-independent 
redox-regulated chaperone in yeast. Get3 is a zinc-binding protein that 
presents four conserved cysteines arranged in a C-X-C-X43-C-XX-C motif 
(corresponding to the region C240 to C288). This arrangement is very 
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similar to the oxidation sensitive zinc-binding motif present in the unrelated 
protein Hsp33, a bacterial redox-regulated ATP-independent chaperone.  
 
The incubation of Get3 with H2O2 and Cu2+, that induces hydroxyl radical 
production, promotes the activation of Get3 as a chaperone holdase. 
Under these conditions, Get3 undergoes massive conformational 
changes, triggered by disulphide bond formation and zinc release. Get3 
rearrangement results in the formation of highly active tetramers and 
higher oligomers that can bind unfolding proteins, preventing their 
aggregation. Interestingly, H/D exchange experiments on reduced and 
oxidized Get3 showed that the region that contains the hydrophobic 
binding site for TA proteins (aa184-201) is the less affected in terms of 
exposure, which in line with the function of Get3 as a redox regulate 
chaperone. 
 
Synthetic genetic array (SGA) analysis in Saccharomyces cerevisiae 
identified genetic interactions under heat shock of GET3, GET1 and GET2 
with NAS6, a chaperone involved in the assembly of the 19S regulatory 
particle of the proteasome as well as genes encoding other proteasome 
assembly chaperones such as HSM3, RPN14 and UMP1 (Akahane et al., 
2013). 
 
Knockdown of TRC40 in HEK293T cells caused accumulation of 
ubiquitinated proteins, reduced peptidase activity of the 20S proteasome 
(core particle) as well as increased levels of the immature 20S 
proteasome. Moreover, Bag6 depleted cells exhibited a defect in the core 
particle quite similar to what was observed in the TRC40 knockdown, 
suggesting that the role of TRC40/Get3 pathway in proteasome assembly 
in conserved from yeast to humans (Akahane et al., 2013). 
 
An extra role of Get3 in signalling mediated by G protein was also 
proposed in yeast (Lee and Dohlman, 2008). Like G protein-couple 
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receptors (GPRCs), Get3 binds directly the G protein Gpa1 accelerating 
its guanine-nucleotide exchange. This promotes G protein-dependent 
cellular responses such as mitogen-activated protein kinase (MAPK) 
phosphorylation. Nevertheless, this role has not been evaluated in the 
case of TRC40. 
Redundancy of the insertion pathways 
Despite the number of substrates handled by the cotranslational SRP and 
the post-translational TRC40/Get pathways, many proteins are known to 
be targeted independently of both routes (Aviram and Schuldiner, 2014). 
These alternative pathways have been extremely difficult to investigate, 
particularly in vivo. A recent study provided important insights in a novel 
pathway, known as the SRP-independent targeting (SND) pathway 
(Aviram et al., 2016). Using a systematic visual screen in Saccharomyces 
cerevisiae, Aviram et. al (2016) described three uncharacterized proteins 
that are involved in the ER targeting of Gas1, a SRP-independent and 
partially Get3-dependent substrate (Ast et al., 2013). The proteins 
identified in the screening, named Snd1, Snd2 and Snd3, act as a backup 
targeting system when the SRP and the Get pathways are impaired.  
 
This study suggests that the SND components might target a very diverse 
range of proteins, particularly substrates with central TMDs. The 
localization of the first TMD within the proteins seems to play a major role 
also in determining the dependency on the SND pathway. Although the 
molecular mechanisms of the SND pathway have not been address yet, it 
is tempting to speculate the way the SND pathway operates, based on 
parallels with the SRP and Get pathways: Snd1, which is thought to be a 
peripherical ribosomal protein (Huh et al., 2003), might be involved in 
capturing  substrates at the ribosome to funnel them to the ER membrane 
through a dedicated receptor (Fig. 2). The receptor might be composed by 
Snd2, Snd3, which form a complex with the Sec61 translocon at the ER 
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membrane, based on the result of a blue-native PAGE analysis (Aviram et 
al., 2016). 
 
Nevertheless, it is not clear whether the SND pathway is also present in 
higher eukaryotes as the only component of the pathway with a direct 
homologue in mammals is Snd2 (TMEM208). 
Animal models of the TRC40-pathway components 
Some of the TRC40 pathway components have been associated with 
human health and disease. For instance, some evidence suggests that the 
ER receptor component WRB, might be involved in congenital heart 
disease, an endemic disorder occurring in 1 % of all live births (Benjamin 
et al., 2017). WRB was initially identified in a screen for genes associated 
to heart disease in Down´s syndrome (DS) patients in a restricted region 
within the chromosome 21 (Egeo et al., 1998) and for that reason WRB is 
also known as congenital heart disease protein 5 (CHD5). Moreover, the 
number of DS patients with congenital heart disease is rather high (35-
60% of individuals affected) (Chaoui et al., 2005; Goodship et al., 1998). 
Nevertheless, the precise role of the WRB/CHD5 during heart 
morphogenesis and physiology is still poorly understood. 
 
In the attempt to examine the physiological impact of the TRC40 pathway 
in vivo, several knockout and knockdown models of different components 
have been generated in different model organisms over the years (Table 
2). However, the identification of TA substrates of the pathway in vivo as 
well as how the pathway is integrated into the cellular proteostasis network 
is poorly understood. 
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Table 2. Animal models of TRC40-pathway components. 
Component Model description Phenotype/main findings References 
TRC40 
(Asna1) 
Constitutive KO mouse. Exons 3, 4, 
5 and part of 6 were replaced with a 
Neomycin cassette. 
Asna1+/- heterozygous mice are healthy and fertile. 
Embrionic lethality of Asna1-/- homozygous at E3.5-E8.5 
(Mukhopadhyay et 
al., 2006)  
TRC40 
(Asna1) 
β-cell specific Asna1 mutant mouse. 
Exon 2 was removed by Cre-LoxP 
system, leading to a frameshift and 
translational termination in exon 3. 
cre under control of one of the Ins1 
alleles. 
Hypoinsulinemia, impaired insulin secretion, glucose 
intolerance and diabetes. The plasma-to-TGN and 
Golgi-to-ER transport pathways are perturbed, probably 
as a result of mislocalization of the TA proteins Stx5, 
Stx6 and Vamp3. Loss of Asna1 leads to ER stress. 
 (Norlin et al., 2015) 
TRC40 
(Asna1) 
knockdown in zebrafish larvae. 
Morpholino antisense 
oligonucleotides targeting the 
translation start site or the exon3-
intron3 splice junction of Asna1 
were used. 
Reduced visual function and synaptic contacts. 
Moreover, TRC40 knockdown phenotype was similar to 
wrbhi1482 mutant model phenotype, described above. 
(Amsterdam et al., 





Constitutive KO mouse. Deletion of 
almost the entire ORF. 
Embryonic lethality associated with developmental 
defects in lung, kidneys and brain shortly after birth. The 
phenotype is associated with dysregulation of apoptosis 
and cell proliferation. Schythe regulates the Apoptosis 
Inducing Factor (AIF). 
(Desmots et al., 
2005; Desmots et 
al., 2008) 
UBL4A 
Constitutive KO mouse. Exons 2 to 
4 were deleted by Cre-LoxP 
system. 
Increased neonatal mortality. Glycogen synthesis is 
lower in Ubl4A KO livers, probably due to decrease of 
glycogen synthase activity. The insulin-induced 
membrane translocation of the Akt kinase is impaired in 
KO primary hepatocytes.  
(Zhao et al., 2015) 
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SGTA 
Cre-loxP Sgta null mouse. Sgta 
gene was floxed at exons 4 and 5, 
which removed the TPR1 motif and 
part of the TPR2 motif. 
Sgta+/- animals are fertile while Sgta-/- is subfertile with 
higher neonatal death. SGTA-null animals present a 
mild phenotype of reduced body size and increase in 
androgen-sensitive organs. 
(Philp et al., 2016) 
WRB 
(CHD5) 
Knockdown in medaka fish (Oryzias 
latipes) embryos. CHD5 initiation 
translation was blocked with a 
specific morpholino antisense 
oligonucleotide. 
WRB mRNA and protein were found to be expressed 
after stage 28 in developing heart (ventricle and atrium). 
WRB depletion caused a severe cardiac disorder (i.e. 
abnormal looping and chamber formation) and ocular 
abnormalities (i.e. cyclopy) by an unknown mechanism. 
(Murata et al., 2009) 
WRB 
(CHD5) 
Knockdown Xenopus laevis 
embryos. CHD5 was targeted with a 
specific morpholino antisense 
oligonucleotide. 
Compromised myocardial integrity, improper deposition 
of the basement membrane, myocydial tissue adhesion 
defects and also abnormal cardiac looping and chamber 
formation. CHD5 is essential for the proper function of 
the transcription factor CASTOR (CASZ1) during cardiac 
morphogenesis. 
(Sojka et al., 2014) 
WRB 
(CHD5) 
Trangenic wrbhi1482 mutant 
zebrafish embryos. wrbhi1482 mutant 
is a null allele that presents an 
insertion of 65 bp of retroviral DNA 
within the first intron of the wrb 
gene. 
WRBhi1482 mutantion was identified in a screening of fish 
mutagenized by retroviral insertion on the basis of 
defective eye movement. mRNA expression of wrb  in 
wrbhi1482 is strongly downregulated. As mentioned 
above, the phenotypes of TRC40 knockdown and 
WRBhi1482 animals are very similar, suggesting that TA 
protein insertion by WRB/TRC40 pathway is required for 
synaptic transmission between photoreceptors and 
bipolar cells. 
(Amsterdam et al., 





Trangenic pwihi1482 mutant zebrafish 
embryos. pwi hi1482 is a null allele 
with proviral insertion at 65 bp after 
the first exon of wrb gene.  
Deafness and blindness, with a clear phenotype on hair 
cells and photoreceptors. pwihi1482 mutation results in 
smaller postsynaptic responses in afferent neurons 
during startle auditory stimuli and impaired transmission 
at the photoreceptor ribbon synapse. These functional 
deficits were supported by a concomitant reduction of 
synaptic markers (Rab3 and CSP). Synaptobrevin 2 and 
syntaxin 3, TA proteins involved in membrane fusion, 
are reduced in mutant retinas. 
(Lin et al., 2016) 
WRB 
(CHD5) 
Conditional inner hair cells 
knockout. Exons 2 to 4 of wrb locus 
were removed by using Cre-LoxP 
system. cre is under control of the 
hair cell-specific vglut3 promoter. 
Hearing impairment. WRB depleted Inner hair cells 
display fewer ribbon-associated vesicles and impaired 
synaptic vesicle replenishment. Otoferlin, a TA protein 
involved in synaptic vesicle fusion and replenishment, is 
reduced in KO hair cells. Otofelin overexpression 
partially rescues the phenotype in the knockout. 
(Vogl et al., 2016) 
CAML Constitutive knockout CAML knockout is embryonically lethal at an early stage (between 7.5 to 12.5 days postcoitum).  (Tran et al., 2002) 
CAML 
Conditional knockout by using Cre-
LoxP system. cre is under control of 
the Ick promoter, active in CD4-
CD8- thymocytes. 
CAML is essential for the development of peripherical T 
cell. Phosphorylation p56Ick and ZAP-70 tyrosine 
kinases and production of IL2 is increased in CAML 
depleted cells. Thymocyte numbers are significantly 
reduced in the KO.  
(Tran et al., 2005) 
CAML 
Conditional, tamoxifen-inducible 
knockout in inner hair cell. cre is 
under control of Atoh1 
Deafness as consequence of loss of cochlear hair cells. (Bryda et al., 2012) 
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Quality control of TA proteins 
Due to their spontaneous propensity to aggregate, the biogenesis of TA 
proteins involves the protection of the TMD from the aqueous media by 
targeting factors such as TRC40/Get3. However, these targeting factors 
may fail to protect the precursor TA protein implying that quality control 
pathways for the degradation of mislocalized membrane proteins (MLPs) 
must also be integrated to the targeting process. 
 
Recent in-vitro studies have shown that the pretargeting component Bag6 
links the pathways of targeting and ubiquitination as it has not only a role 
during delivery of TA proteins to the ER but also a central function during 
clearing of MLPs, including TA proteins that failed to engage the TRC40 
pathway (Hessa et al., 2011). Under normal conditions, TA proteins clients 
of Bag6 are transferred from SGTA to TRC40, whereas the remainder are 
efficiently ubiquitinated and degraded by the proteasome. Indeed, it is 
thought that Bag6 is able to distinguish MLPs from nascent cytosolic 
proteins, as MLPs present long hydrophobic stretches, while nascent 
cytosolic proteins contain shorter or moderately hydrophobic segments. 
 
Based on in-vitro crosslinking, Hessa et al. (2011) identified the E3 ligase 
ring finger protein 126 (RNF126) and the E2 enzyme UbcH5, which are 
required for the ubiquitylation of MLPs, including the TA protein Sec61β. 
However, the ubiquitylation of this TA substrate in the presence of TRC40 
was slower compared to the ubiquitylation of the mammalian prion protein 
(PrP), a MLP from the class of GPI-anchored proteins. Remarkably, the 
depletion of TRC40 during the assay resulted in ubiquitylation of Sec61β, 




Bag6 is a long protein of ∼1200 amino acids with several functional 
domains (Shao and Hegde, 2016): the C-terminus of Bag6 mediates the 
transfer of the TA protein to TRC40 by forming a complex with the 
cofactors TRC35 and Ubl4A (Mock et al., 2015), the middle region binds 
the substrate (MLP) (Leznicki et al., 2013) and its N-terminus contains an 
ubiquitin-like domain (Ubl domain) that is responsible of the recruitment 
RNF126 and subsequently UbcH5 (Hessa et al., 2011). 
 
Leznicki et. al. (2012) showed that the Bag6-dependent ubiquitylation of 
MLPs is completely reversible in a process that involves SGTA. Although 
the molecular mechanism behind this phenomenon is not well understood, 
it is clear that SGTA promotes the deubiquitylation by a deubiquitinase 
(probably UCH37), regulates the access of MLPs to the proteolytic core of 
the proteasome, and competes with RNF126 for Bag6-Ubl, providing a 
rescue pathway for potentially viable TA proteins that were prematurely 
ubiquitylated by Bag6 (Krysztofinska et al., 2016; Leznicki and High, 2012; 
Leznicki et al., 2015; Wunderley et al., 2014). 
 
Nevertheless, it is important to highlight that Bag6 is not present in yeast, 
which opens the question how is the quality control of TA proteins and 
MLPs on this organism. Previous studies in Saccharomyces cerevisiae 
showed that the disruption of GET system components exacerbates the 
accumulation of mislocalized ER TA proteins to mitochondria (Jonikas et 
al., 2009; Schuldiner et al., 2008). Recently, an evolutionarily conserved 
system that clears mistargeted TA proteins on the outer mitochondrial 
membrane (OMM) was described in yeast and mammals by two groups in 
parallel (Chen et al., 2014; Okreglak and Walter, 2014). It was 
demonstrated that the AAA+ ATPase Msp1 not only interacts with the ER 
TA proteins Pex15 and Gos1, but also actively extracts them from OMM, 
limiting their mislocalization to mitochondria in yeast (Chen et al., 2014). 
Knockout of MSP1 resulted in growth defects and severe mitochondrial 
damage, particularly when combined with GET pathway knockouts. These 
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growth defects were particularly severe in the double-deletion strains of 
msp1 and GET components (Δget1, Δget2, Δget3, Δget4, Δget5, Δsgt2), 
especially when they were grown on glycerol-containing medium (in which 
mitochondrial respiration is required) or under heat shock conditions. 
 
 
Figure 5. Clearance of mislocalized ER TA proteins from cytosol (1) and 
from the mitochondria (2). SGTA limits Bag6-mediated degradation 
probably at the proteasome (3). Ubiquitin receptors (Rpn10 and Rpn13) 
might recruit Bag6, SGTA and a deubiquitinase(s) to the 19S particle of 

































The mitochondrial/respiration phenotype observed was more severe in the 
cases of double-deletion mutants of msp1 with Δget1, Δget2 or Δget3. This 
phenotype was characterized by a strong reduction of mtDNA-encoded 
(i.e. Cox2, Cox3) and nuclear-encoded mitochondrial proteins (i.e. Atp2, 
Sdh1, Sdh2, Por1 and Om45), due, at least In part, to lack of functional 
mtDNA.  
 
Msp1 is homolog of the mitochondrial-peroxisomal ATAD1 in mammals 
(Okreglak and Walter, 2014). Like Msp1, ATAD1 limits the mitochondrial 
mislocalization of the ER TA proteins PEX26 and GOS28, orthologs of 
yeast Pex15 and Gos1, respectively. Moreover, depletion of ATAD1 in an 
ATAD1-/- mouse leads to decreased levels of mitochondrial proteins (i.e. 
TOMM20, COX1, COX4, HXK1, VDAC1) and mitochondrial fragmentation, 
which correlates the results obtained in yeast (Okreglak and Walter, 
2014). 
 
Nevertheless, the role of quality control pathways in the clearance of other 




Scope of the thesis 
 
Although the TRC40/Get pathway is considered as the main targeting 
system of TA proteins, a direct role in vivo has been confirmed only for a 
very small number of TA proteins. Moreover, considering the recent 
description of redundant targeting components (i.e. SNDs), it is timely to 
rigorously identify the TA-proteins that depend, on TRC40/Get3 at the 
steady-state level. 
 
This work aims at gaining a deeper understanding of the physiological role 
of the TRC40 pathway during the biogenesis of candidate TA proteins in 
native terminally differentiated cells of the mouse. Along this line, the 
integration of the pathway with the cellular proteostasis network in vivo, 
where quality control pathways also play a major role, is considered. I 
focus on the mechanism behind the integration and trafficking of emerin, a 
TA protein that is targeted to the INM. Emerin was selected due to its 
unique role in muscle cells and its clinical relevance in the Emery-Dreifuss 
Muscular Dystrophy and because several mutations affecting emerin´s 
TMD have been reported in patients. 
 
As the fundamental model of the present study, I have generated and 
characterize here a heart-specific, tamoxifen-inducible knockout of WRB. 
Complementary in-vivo and in-vitro approaches are used to follow the fate 
of several TA proteins once the TRC40 pathway is impaired; moreover, 






Manuscript 1: Emery-Dreifuss muscular dystrophy mutations 
impair TRC40-mediated targeting of emerin to the inner nuclear 
membrane.
RESEARCH ARTICLE
Emery–Dreifuss muscular dystrophy mutations impair
TRC40-mediated targeting of emerin to the inner nuclear
membrane
Janine Pfaff1,*, Jhon Rivera Monroy1,*, Cara Jamieson1, Kalpana Rajanala1, Fabio Vilardi1,
Blanche Schwappach1,2,‡ and Ralph H. Kehlenbach1,‡
ABSTRACT
Emerin is a tail-anchored protein that is found predominantly at the
inner nuclear membrane (INM), where it associates with components
of the nuclear lamina. Mutations in the emerin gene cause Emery–
Dreifuss muscular dystrophy (EDMD), an X-linked recessive disease.
Here, we report that the TRC40/GET pathway for post-translational
insertion of tail-anchored proteins into membranes is involved in
emerin-trafficking. Using proximity ligation assays, we show that
emerin interacts with TRC40 in situ. Emerin expressed in bacteria or
in a cell-free lysate was inserted into microsomal membranes in an
ATP- and TRC40-dependent manner. Dominant-negative fragments
of the TRC40-receptor proteins WRB and CAML (also known as
CAMLG) inhibited membrane insertion. A rapamycin-based
dimerization assay revealed correct transport of wild-type emerin to
the INM, whereas TRC40-binding, membrane integration and INM-
targeting of emerin mutant proteins that occur in EDMD was
disturbed. Our results suggest that the mode of membrane
integration contributes to correct targeting of emerin to the INM.
KEY WORDS: CAML, TRC40, WRB, Emerin, Inner nuclear
membrane, Tail-anchored protein
INTRODUCTION
The nuclear envelope, which separates the nuclear and the
cytoplasmic compartments, comprises three functional domains.
The outer nuclear membrane (ONM) is continuous with the
endoplasmic reticulum (ER) and thus equipped with a very similar
set of membrane proteins and is also studded with ribosomes. In
contrast, the inner nuclear membrane (INM) contains a distinct set
of membrane proteins, some of which interact with the underlying
nuclear lamina and/or with chromatin. Both membranes are
connected at the level of the nuclear pore complex (NPC), a large
multi-protein structure that mediates transport of macromolecules
between the nucleus and the cytoplasm. Hence, the ONM, the INM
and the small membrane patches within the NPCs can be considered
as three components of a single membrane system.
A large number of proteins that are specific for, or at least
enriched at, the INM have been identified, mostly by proteomic
approaches (Korfali et al., 2012; Schirmer et al., 2003). One of the
best-characterized INM proteins is emerin, a member of the LEM-
domain family of proteins, which also contains the lamina-
associated polypeptide 2 beta (LAP2β; Foisner and Gerace, 1993;
Furukawa et al., 1995) and MAN1 (also known as LEMD3) (Lin
et al., 2000). The LEM-domain is a helix-loop-helix fold of ∼40
amino acid residues that serves as a binding site for the chromatin-
associated protein barrier to autoregulation factor (BAF, also known
as BANF1). Emerin was originally identified as an X-linked gene
that is mutated in patients with a certain form of Emery–Dreifuss
muscular dystrophy (EDMD; Bione et al., 1994), a disease that
leads to progressive skeletal muscleweakness and wasting as well as
cardiomyopathies. Although a complete loss of emerin does not
result in a particularly strong phenotype in knockout mice (Ozawa
et al., 2006), several mutations that lead to single amino acid
changes and/or frameshifts have been identified in patients affected
by EDMD (see the EDMD database at http://www.dmd.nl/nmdb/
home.php?select_db=EMD). Most of these mutations lead to
premature termination of translation of the emerin mRNA and to
loss of protein or unstable proteins (Manilal et al., 1998b; Nagano
et al., 1996), although other mutations can lead to changes in the
subcellular localization of emerin and aberrant functions (Ellis et al.,
1998).
Emerin is a tail-anchored membrane protein of 254 residues with
a single predicted transmembrane domain close to its C-terminal
end and no signal peptide. Based on these topological features, the
protein has been suggested to be post-translationally inserted into
the cellular membrane system (Ellis et al., 1998). Such a
mechanism, which is distinct from the classic pathway for signal
recognition particle (SRP)-dependent insertion, was originally
postulated for proteins whose C-terminal transmembrane domain
cannot emerge from the ribosome before termination of translation
(Kutay et al., 1993). A bioinformatics approach yielded ∼400
potential human tail-anchored proteins (Kalbfleisch et al., 2007).
Most tail-anchored proteins are thought to integrate into the ER
membrane, although targeting to other organelles (e.g. peroxisomes
or mitochondria) is possible (Hegde and Keenan, 2011). For
insertion into the ER, conserved machinery has been identified in
yeast and in mammalian cells. Important players are TRC40
[transmembrane domain recognition complex protein of 40 kDa,
also known as ASNA1; guided entry of tail-anchored proteins 3
(Get3) in yeast], a protein that associates with the hydrophobic
stretch of amino acids at the C-terminus of tail-anchored proteins
(Favaloro et al., 2008; Stefanovic and Hegde, 2007), WRB
(tryptophan-rich basic protein; Get1 in yeast) (Vilardi et al., 2011)
and the mammalian-specific protein CAML [Ca2+-modulating
cyclophilin ligand, also known as CAMLG (Yamamoto and
Sakisaka, 2012)]. Together, WRB and CAML function as the
TRC40 receptor at the ER membrane (Vilardi et al., 2011, 2014;
Yamamoto and Sakisaka, 2012). Furthermore, chaperone-likeReceived 19 August 2015; Accepted 14 December 2015
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components, such as SGTA and BAG6, capture the C-terminal
transmembrane domains as they emerge from the ribosome and then
deliver tail-anchored proteins to TRC40 (Leznicki et al., 2010;
Mariappan et al., 2010). However, a subset of tail-anchored proteins
seems to be targeted to membranes independently of the TRC40
pathway (Rabu et al., 2008) and cytochrome b5, for example, can be
integrated into ER membranes in an unassisted manner (Colombo
et al., 2009).
After membrane integration into the ER, emerin has to find its
way to its final destination, the INM (Manilal et al., 1998a).
Compared to nuclear import of soluble proteins, targeting of
proteins to the INM is not well characterized (Burns and Wente,
2012; Ungricht and Kutay, 2015; Zuleger et al., 2012). Soullam and
Worman (1995) identified specific INM-targeting signals within a
nuclear region of the lamin B receptor (LBR), which comprises
eight predicted transmembrane domains. Furthermore, the size of
the nuclear region of the protein was suggested as a limiting factor
for efficient transport to its final destination. Very recently, models
that posit diffusion and retention as major determinants of INM
localization of proteins have gained a lot of support (Boni et al.,
2015; Ungricht et al., 2015). An energy requirement that had
originally been observed for transport of proteins to the INM (Ohba
et al., 2004) was attributed to ATP-dependent changes of ER
structures that affect the diffusional mobility of proteins within the
membrane system (Ungricht et al., 2015). In line with this
interpretation, localization of emerin to the INM depends on its
interaction with A-type lamins (Vaughan et al., 2001) and/or
nesprins (Wheeler et al., 2007). As a result of retention at its binding
site, the mobility of emerin at the INM is significantly reduced
compared to that of overexpressed emerin localizing to the ER
(Östlund et al., 1999). A subset of proteins, however, might also use
active import pathways for transport to the INM (King et al., 2006;
Kralt et al., 2015; Laba et al., 2015).
Besides the INM, emerin has been reported to localize to the
peripheral ER and to the ONM, where it has been found to associate
with the centrosome (Salpingidou et al., 2007), and to the plasma
membrane, for example in adherens junctions of intercalated disks
of cardiomyocytes (Cartegni et al., 1997). Despite this very diverse
intracellular localization pattern of emerin, rather little is known
about its mechanisms of membrane integration and subcellular
trafficking. Early experiments with in-vitro-translated emerin
suggested that the protein can indeed be post-translationally
inserted into microsomal membranes (Ellis et al., 1998). In our
study, we now provide evidence for a role of the TRC40 system in
the post-translational ER membrane integration of emerin, and we
analyze several emerin mutants associated with EDMDwith respect
to TRC40 binding, membrane integration and targeting to the INM.
RESULTS
Post-translational membrane integration of emerin by the
TRC40 pathway
Emerin has been suggested to use the TRC40 pathway for
membrane integration of tail-anchored proteins (Laba et al., 2014),
but experimental evidence has not been available. Very
recently, the crystal structure of the C-terminal transmembrane
domain of the yeast tail-anchored protein Pep12 in a complex
with its targeting factor Get3 has been solved (Mateja et al., 2015).
The structure revealed a hydrophobic groove formed by a
Get3 homodimer that shields the hydrophobic transmembrane
domain of its substrate. We compared the properties of the
transmembrane domains of Pep12 and emerin using a helical
wheel projection (http://emboss.bioinformatics.nl/cgi-bin/emboss/
pepwheel; Fig. 1A). Strikingly, six out of 20 of the characteristic
amino acid residues of the transmembrane domains are identical.
In addition to the typical tail-anchored protein topology, this
suggests that emerin might use the mammalian homologue of
Get3, TRC40, to assist in post-translational membrane integration.
We therefore used a system for the purification of tail-anchored
proteins in a complex with TRC40, shielding the hydrophobic
transmembrane domain and protecting the tail-anchored protein
from aggregation. Emerin was expressed in bacteria as a fusion
protein carrying an N-terminal HZZ tag (i.e. a His tag linked to an
IgG-binding ZZ-domain) and a C-terminal N-glycosylation site
(an ‘opsin’ tag), together with maltose-binding protein (MBP)-
tagged TRC40, and purified using Ni-NTA- and amylose beads
(Fig. 1B). Typically, this strategy yielded ∼0.3–1.2 mg of wild-
type protein per liter of bacterial culture, and the two proteins
co-purified perfectly. This result demonstrates that emerin can
indeed form stable complexes with TRC40.
Post-translational membrane integration of in-vitro-translated
emerin has previously been addressed (Ellis et al., 1998). In that
study, microsomal-membrane-associated emerin was sensitive to
protease treatment, suggesting a type II orientation of the protein
with its short C-terminal region behind the transmembrane domain
facing the lumen of the microsomes. Protection of this short
peptide from proteolysis, however, was not demonstrated (Ellis
et al., 1998), presumably due to its small size. To unequivocally
confirm post-translational membrane integration of emerin leading
to a lumenal C-terminus of the protein, we took advantage of an
assay where an N-glycosylation site (opsin tag) fused to the C-
terminus of the protein of interest can be modified by lumenal
glycosyl transferases (Pedrazzini et al., 2000). The purified MBP–
TRC40 and HZZ–emerin–opsin complex was incubated with
rough microsomes from dog to assess post-translational membrane
integration. A shift in molecular mass indicates N-glycosylation of
the reporter protein, a reaction that is specific for the ER or, in this
assay, the microsomal lumen. As shown in Fig. 1C, the addition of
microsomes to the reaction resulted in a significant portion of a
slower migrating form of emerin as compared to a reaction lacking
microsomes, indicating post-translational modification(s).
Furthermore, we observed a smear of high molecular mass forms
of emerin. When the sample was treated with endoglycosidase H
(EndoH) after the reaction, a slow-migrating form of emerin was
partially lost and the faster migrating form became more
prominent, demonstrating that the protein had originally been N-
glycosylated. Consequently, the opsin tag with its N-glycosylation
site must have reached the microsomal lumen, confirming
membrane insertion of the tail-anchored protein. Addition of
lambda-phosphatase largely abolished the smear of higher
molecular mass forms, in agreement with earlier observations
that emerin can be phosphorylated (Ellis et al., 1998; Leach et al.,
2007; Roberts et al., 2006). TRC40-dependent membrane
integration of tail-anchored proteins is an active, ATP-dependent
process (Favaloro et al., 2008, 2010; Stefanovic and Hegde, 2007).
Accordingly, the portion of the slower migrating form of emerin
was clearly reduced when ATP was omitted from the reaction
(Fig. 1D,E). We also performed reactions with microsomes that had
been treated with trypsin to remove potential receptor proteins from
the membranes. In these assays, the fraction that shifted in
molecular mass was clearly reduced, suggesting that membrane
insertion of emerin occurred in a receptor-dependent manner (data
not shown). Finally, the addition of fragments of the TRC40-
receptor proteins WRB or CAML to the reaction almost completely
prevented the shift in molecular mass (Fig. 1D,E), suggesting that
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the fragments function as dominant-negative inhibitors of TRC40-
mediated membrane integration, as shown previously for other tail-
anchored proteins (Vilardi et al., 2011; Yamamoto and Sakisaka,
2012).
The system described above uses emerin in a pre-assembled
complex with TRC40. To analyze the TRC40-dependent membrane
integration of emerin in a less biased manner, we took advantage of
a coupled in vitro transcription–translation system. As shown in
Fig. 2A, emerin–opsin was synthesized in vitro in a plasmid-
dependent manner. In the presence of rough microsomes, a shift in
molecular mass was observed, which could be reversed by treating
the reaction product with EndoH. Thus, the in vitro system
Fig. 1. The TRC40-pathway mediates the insertion of emerin into ER-enriched membranes. (A) Helical wheel projections of transmembrane domains of
Pep12 and emerin. Hydrophobic residues are colored in magenta, aromatic residues in light blue and positively charged residues in green. The gray circles
indicate identical residues between Pep12 and emerin. (B) Co-purification of the recombinant MBP–TRC40 and HZZ–emerin–opsin (op) complex from E. coli by
Ni-NTA and amylose resins. UC, ultracentrifugation; FT, flow-through. (C) In vitro insertion of HZZ–emerin-op into roughmicrosomes (RM). TheMBP–TRC40 and
HZZ–emerin–opsin complexes were incubated with (+) or without (−) RM.Where indicated, EndoH or lambda phosphatase (λPPase) treatments were carried out
after integration. WB, western blotting; G indicates the glycosylated form. (D) Effects of ATP depletion and WRBcc or CAML-N fragments (10 µM each) on
membrane integration of HZZ–emerin–opsin. (E) Quantification of relative amounts of glycosylated (i.e. membrane inserted) emerin–opsin under different
conditions as in D. Error bars indicate the s.d. of four independent experiments. *P<0.05; ***P<0.001 (Student’s t-test).
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recapitulates microsome-dependent N-glycosylation of the reporter
protein and, hence, membrane integration, similar to the assay
presented in Fig. 1. Next, we depleted the reticulocyte lysate that
was used for in vitro translation using specific antibodies against
TRC40 or, as a control, the chaperone HSC70 (also known as
HSPA8) (Fig. 2B). Strikingly, the depletion of TRC40 from the
lysate resulted in a strong reduction of N-glycosylation (i.e.
membrane integration) of in-vitro-translated emerin compared to
mock-treated or HSC70-depleted lysates (Fig. 2C). Taken together,
these results show that opsin-tagged emerin can be post-
translationally inserted into microsomal membranes in a TRC40-,
WRB- and CAML-assisted manner.
Next, we set out to establish a membrane-integration assay for
emerin in permeabilized cells. HeLa cells were treated with
digitonin to preferentially permeabilize the plasma membrane and
were then incubated with the purified MBP–TRC40 and HZZ–
emerin–opsin complex. Similar to dog microsomes, the
permeabilized cells were able to post-translationally insert emerin
into ERmembranes in an ATP- and temperature-dependent manner,
as concluded from the observed shift in the molecular mass of the
reporter protein. Again, insertion could be suppressed with WRB or
CAML fragments, indicating a role for the TRC40 system (Fig. 3A).
To confirm N-glycosylation as the basis for the observed shift in
molecular mass, we treated the permeabilized cells with Peptide-N-
glycosidase F (PNGaseF) after the first reaction. Similar to our
observation with EndoH (Fig. 1C), this treatment resulted in a
complete loss of the slowly migrating form of emerin with a
concomitant increase in intensity of the faster migrating (i.e.
deglycosylated) form (Fig. 3B).
Taken together, these results suggest post-translational
membrane insertion of emerin through the TRC40–WRB–CAML
system under conditions where emerin is presented to the
permeabilized cells or microsomes as a preformed TRC40
complex (Figs 1 and 3) or expressed in an in vitro system (Fig. 2).
Next, we asked whether interactions of emerin with the TRC40
system could be detected in situ, and we used a proximity ligation
(Duolink) assay (PLA) (Söderberg et al., 2006) to address this
question. This assay is based on the decoration of proteins present in
a complex or in close vicinity in fixed cells with specific primary-
and oligonucleotide-linked secondary antibodies. If the target
proteins are in close proximity, subsequent ligation and
amplification reactions lead to a fluorescent product that can
easily be detected by microscopy (Söderberg et al., 2006; Fig. 4A).
To demonstrate the suitability of our anti-emerin antibodies, we first
set out to detect the well-established interaction of emerin with
Fig. 2. In vitro translation and TRC40-dependent membrane insertion of
emerin. (A) Opsin-tagged emerin (emerin-op) was produced in vitro by
coupled transcription–translation in the absence (−) or presence (+) of rough
microsomes (RM) and with (+) or without (−) subsequent treatment with
EndoH. (B) Lysates used for coupled transcription–translation reactions were
immunodepleted using antibodies against TRC40 or HSC70. (C) Depleted
lysates (mock, anti-TRC40 and anti-HSC70 antibodies) were used for
reactions as in A. In A–C, proteins were analyzed by SDS-PAGE, followed by
immunoblotting (WB) using appropriate antibodies, as indicated. G indicates
the glycosylated form.
Fig. 3. Post-translational insertion of
emerin into membranes of semi-
permeabilized cells. (A) HeLa cells were
permeabilized with digitonin and
incubated with purified HZZ–emerin–
opsin (op) and MBP–TRC40 at 4°C or
30°C, with or without energy (+/− ATP)
and increasing amounts of MBP–WRBcc
or GST–CAML-N, as indicated. (B) After a
reaction as in A at 30°C in the presence of
ATP, portions of the reaction were left
untreated (80%, −) or further incubated
with (PNGaseF) or without (buffer; 10%
each) the PNGaseF. In A and B, proteins
were analyzed by SDS-PAGE, followed
by immunoblotting (WB) using the
indicated primary antibodies. Calnexin
served as a loading control. G indicates
the glycosylated form of emerin.
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lamins at the INM (Vaughan et al., 2001; Fig. 4B). After fixation
and permeabilization, cells were treated with antibodies against
endogenous emerin and/or lamin A/C and subjected to the Duolink
assay. After the reaction, red dots indicate sites where two proteins
exist in proximity. When both antibodies were applied together,
essentially all cells showed red fluorescent signals exclusively at the
nuclear rim, indicating the interaction of emerin and lamin A/C at
the INM. No signals were detected when only one of the primary
antibodies was used, demonstrating the specificity of the reaction
(Fig. 4B). Next, cells were transfected with Myc-tagged TRC40
and subjected to PLAs using antibodies against the Myc tag
and different endogenous membrane proteins: (1) Sec61β, an
established tail-anchored protein andmodel protein used in studying
the TRC40 system (Favaloro et al., 2008; Stefanovic and Hegde,
2007); (2) STT3B, an oligosaccharyltransferase that should
integrate into ER membranes with the help of the SRP; and (3)
emerin. Myc–TRC40 was found in cytoplasmic regions and largely
excluded from the nucleus. As shown in Fig. 4C,D, no dots were
Fig. 4. In situ PLA detection of TRC40–emerin interactions.
(A) Schematic diagram of the in situ PLA strategy showing
primary antibodies and PLA probes binding to target proteins.
Close proximity of the secondary PLA probes allows ligation
followed by rolling circle amplification. (B) Intracellular localization
of emerin and lamin A/C complexes using the Duolink in situ PLA
assay in HeLa cells. PLA signals of single proteins (emerin or
lamin) or protein–protein complexes (emerin–lamin) are
displayed. Each red dot represents a single protein–protein
interaction. Nuclei were stained with DAPI (blue) and
representative images are shown. (C) HeLa cells were
transfected with a plasmid coding for TRC40–Myc prior to
staining with anti-Myc, -emerin, -Sec61β (positive control) or
-STT3B (negative control) antibodies to detect interactions using
the PLA. Cells were then stained for TRC40–Myc (green) and
DAPI (blue). Left panel, negative controls, with only one primary
antibody for the targeted protein–protein interaction. Right panel,
dual antibody PLA. Representative confocal images are shown.
Scale bars: 10 µm. (D) The dot plot represents the number of PLA
dots per cell for both the single antibody controls and protein–
protein interactions with mean values (blue bars) and s.d. (error
bars) shown. 100 cells were scored over two independent
experiments.
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detected in cells that had been treated with either one of the
individual antibodies alone. A strong signal (∼56 dots per cell) was
observed with antibodies against Sec61β, our positive control, and
the Myc–TRC40. The negative control, STT3B, yielded only very
few dots per cell. Clearly, a specific interaction of emerin withMyc–
TRC40 could be observed with an average of 12 red dots per
transfected cell. For both Sec61β and emerin, the dots were mostly
excluded from the nuclear region of the cells, further demonstrating
the specificity of the detection.
In summary, these results show that transient interactions of
emerin with TRC40 can be detected in situ and strongly suggest a
physiological role for the TRC40 system in membrane integration of
this tail-anchored protein. To further establish such a role in living
cells, we established conditions for small interfering RNA (siRNA)-
mediated knockdown of TRC40 and analyzed targeting of
endogenous emerin to the nuclear envelope in knockdown cells
and in control cells. As a control, we detected the INM protein LBR
(Soullam and Worman, 1995). LBR is co-translationally inserted
into the ER membrane and, hence, does not require the TRC40
pathway. Treatment of cells with specific siRNAs resulted in a
clear reduction of TRC40 levels, as detected by indirect
immunofluorescence (Fig. 5A,B) or western blotting (Fig. 5C).
Inspection of emerin levels at the nuclear envelope revealed a clear
reduction of the protein in TRC40-knockdown cells compared to
control cells (Fig. 5A,B), whereas the total levels remained
unchanged (Fig. 5C). LBR and STT3B, by contrast, were not
affected by the siRNAs (Fig. 5A,B). These results show that targeting
of emerin to the cellular membrane system is reduced in TRC40-
depleted cells and they suggest that the non-targeted protein does not
give rise to a strong signal in immunofluorescence microscopy.
Membrane integration of EDMD mutants of emerin
Having established the TRC40 pathway as a major route in post-
translational membrane integration of emerin, we next analyzed
the role of the C-terminal region of emerin in detail. Several
mutations within the transmembrane domain or in its close
proximity have been associated with EDMD (Ellis et al., 1998;
Manilal et al., 1998b; Mora et al., 1997; Nagano et al., 1996;
Nigro et al., 1995; Ognibene et al., 1999; Vohanka et al., 2001;
Yates et al., 1999). We selected several emerin mutants with
increasing levels of expected severity (i.e. from point mutants
with single amino acid changes to mutants lacking the entire
transmembrane domain; Fig. 6A). The Gln228His mutant was
originally identified in a patient with X-linked mental retardation
(Tarpey et al., 2009) and has not been linked to EDMD, and serves
as a control for our analyses. A hydrophobicity plot of the C-
terminal region of wild-type emerin and these mutants confirmed
the expected changes (Fig. 6B): for the Pro183Thr, the Pro183His
and the Gln228His mutant, the plot was almost identical to that
of wild-type emerin. The stop codon mutation Trp226* (i.e.
translation terminates after Leu225) and the frame shift mutation
Leu225Arg-FS essentially abolished the transmembrane domain,
whereas the Phe240His-FS mutation and the deletion ΔVal236-
Phe241 resulted in shorter hydrophobic domains of the
corresponding proteins. For the latter two proteins and for wild-
type emerin, we also predicted ΔG-values for insertion of putative
transmembrane helices into membranes (Hessa et al., 2007). The
ΔG-prediction server (http://dgpred.cbr.su.se/index.php?p=home)
yielded values of −4.288, −1.791 and 0.642 kcal/mol for wild-
type emerin, emerin-Phe240His-FS and emerin-ΔVal236-Phe241,
respectively, confirming that these mutations result in less
hydrophobic transmembrane domains.
Next, we co-expressed MBP–TRC40 and wild-type (compare
Fig. 1B) or mutant forms of His- and opsin-tagged emerin in
bacteria (Fig. 6C). The three point mutants Pro183Thr, Pro183His
and Gln228His yielded similar levels of TRC40–HZZ–emerin
complexes as the wild-type protein, whereas for emerin-Trp226*,
Leu225Arg-FS and Phe240His-FS, as well as the deletion
ΔVal236-Phe241, substantially less HZZ–emerin–opsin was
recovered during the purification, indicating reduced interaction
Fig. 5. Depletion of TRC40 results in
reduced levels of emerin at the nuclear
envelope. (A) HeLa cells were treated with a
final concentration of 170 nM of specific
siRNAs to reduce the levels of endogenous
TRC40 (siTRC40) or control siRNAs (siCTRL)
and subjected to indirect immunofluorescence
detecting TRC40 and emerin or, on separate
slides, LBR and STT3B, as indicated. Scale
bar: 20 µm. Very similar results were obtained
with siRNA concentrations as low as 50 nM.
(B) Quantification of the results in A. Error bars
represent the s.d. from the mean fluorescence
values from 100 cells over two independent
experiments. ***P<0.001 (Student’s t-test).
(C) Western blot of cell lysates of control cells
or knockdown cells. Calnexin was used as a
loading control.
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with MBP–TRC40 (Fig. 6C). Equivalent amounts of purified
emerin variants were then subjected to glycosylation assays using
microsomal membranes. As shown in Fig. 6D,E, the Gln228His
mutation hardly affected the degree of glycosylation (i.e. membrane
integration), whereas for the Pro183Thr and Pro183His mutant,
significantly less glycosylation was observed. The frame shift
mutation Phe240His-FS and the deletion ΔVal236-Phe241 strongly
reduced the efficiency of membrane integration of the respective
proteins. These results show that TRC40-dependent membrane
insertion of emerin can be affected by mutations within the
transmembrane domain and, surprisingly, by single amino acid
changes ∼40 residues upstream of the transmembrane domain.
Targeting of emerin and emerin mutants to the INM
The most prominent localization of emerin is at the INM, although
other localizations have been described. We therefore used
transfection experiments and indirect immunofluorescence to
compare the subcellular localization of our mutant forms of
emerin with that of the wild-type protein. As expected, after
fixation and Triton X-100 permeabilization of cells, HA-tagged
wild-type emerin was predominantly found at the nuclear rim
(Fig. 7). A similar pattern was observed for the three point mutants
Pro183Thr, Pro183His and Gln228His, with some cell-to-cell
variations regarding the level of extra-nuclear (i.e. presumably ER-
associated) HA–emerin. The mutants Leu225Arg-FS and Trp226*
Fig. 6. Emerin diseasemutants display impaired interaction with TRC40 and reducedmembrane interaction. (A) Scheme of the emerin variants analyzed
in this study. The transmembrane domain (TMD) is shown in red. Predicted TMDs in emerin variants are highlighted with a red line. TMDs of wild-type (WT)
and Leu225Arg-FS, ΔVal236-Phe241, Phe240His-FS emerin variants are specified in detail below. (B) Kyte–Doolittle hydrophobicity plots for the C-terminal
portion of the emerin mutants. (C) Co-purification of MBP–TRC40 and HZZ–emerin–opsin (op) complexes. Purified proteins were subjected to SDS-PAGE
followed by western blotting detecting TRC40 and the opsin tag of the emerin variants. (D) In vitro insertion assay of HZZ–emerin–opsin variants into rough
microsomes. Variants Trp226* and Leu225Arg-FS, which lack a transmembrane domain, were omitted from the analysis. G indicates the glycosylated form.
(E) Quantification of the results in D. Relative amounts of glycosylated (i.e. membrane inserted) emerin mutants are depicted. Error bars indicate the s.d. of four
independent experiments. *P<0.05; ***P<0.001 (Student’s t-test).
508












as well as the deletion ΔVal236-Phe241 showed almost no
localization to the nuclear rim and were found all over the cells.
Interestingly, the frame shift mutant Phe240His-FS, which hardly
interacted with MBP–TRC40 (Fig. 6C) and was the least efficient in
the membrane integration assay (Fig. 6D,E), was found at the
nuclear rim, very similar to wild-type emerin. To discriminate
Fig. 7. Subcellular localization of emerin variants.HeLa cells
were transfected with plasmids coding for HA–emerin variants,
permeabilized either with Triton X-100 or digitonin and
immunostained using antibodies against the HA tag.
Endogenous lamin A/C immunostaining (top row) was used as a
control for differential permeabilization. Scale bars: 15 µm.
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between protein localization at the INM versus the ONM, we also
performed immunostaining of cells subjected to differential
permeabilization. Using the detergent digitonin, proteins of the
INM should not be accessible to the primary antibody. Accordingly,
our endogenous control protein of the INM, lamin A/C, was not
detectable in digitonin-permeabilized cells, whereas a characteristic
nuclear rim was observed after permeabilization with the detergent
Triton X-100 (Fig. 7, top row). For HA-tagged wild-type emerin, a
clear extra-nuclear signal was visible upon digitonin-treatment.
Signal intensities at the nuclear rim, however, were reduced
compared to Triton-X-100-treated cells, as expected. This result
suggests that overexpressed HA–emerin partially reaches the INM
and is partially sequestered at the ER and the ONM (as indicated by
the digitonin experiment). For the Pro183 mutants and the
Gln228His mutant, similar observations were made with clear,
albeit weak signals, at the nuclear rim. The two emerin mutants
lacking a transmembrane domain (Leu225Arg-FS and Trp226*)
yielded only very weak signals in the digitonin-permeabilized cells,
because the proteins are expected to be soluble and should be
released from the cells upon treatment with the detergent. The
deletion mutant ΔVal236-Phe241 exhibited similar signals upon
Triton X-100 or digitonin treatment, without a pronounced staining
at the nuclear rim. Strikingly, the emerin mutant Phe240His-FS
appeared very similar in Triton-X-100- or digitonin-treated cells,
with a clear nuclear rim under both conditions, suggesting that the
protein localizes predominantly to the ONM. Taken together, our
differential permeabilization experiments suggest that certain
mutations in the emerin gene not only affect membrane
integration of emerin but also its correct targeting to the INM.
To corroborate these results, we established an assay to
specifically assess targeting of a reporter protein to the INM,
similar to a previously published approach (Ohba et al., 2004). The
system is based on induced dimerization of proteins carrying
appropriate binding domains for rapamycin (Chen et al., 1995).
Rapamycin binds to the 12-kDa FK506 binding protein (FKBP12)
as well as a 100-amino-acid domain of mammalian target of
rapamycin (mTOR), known as the FKBP-rapamycin binding
domain (FRB; Fig. 8A). Thus, rapamycin should recruit a soluble
nuclear reporter protein containing an FKBP12-domain (GFP2–
GST–NLS–FKBP12) to the INM if an FRB-containing protein (e.g.
FRB–emerin) is present at this specific location. In our system,
mCherry–FRB–emerin was expressed in cells together with GFP2–
GST–NLS–FKBP12, which showed a typical nuclear localization
in the absence of rapamycin (Fig. 8B). Addition of rapamycin to the
cells led to a very clear re-distribution of GFP2–GST–NLS–
FKBP12 to the nuclear periphery, resulting from drug-induced
dimerization with the INM protein mCherry–FRB–emerin. As a
control, we expressed WRB–FRB–HA together with the GFP
reporter. At first inspection, WRB–FRB–HA showed a similar
subcellular localization to mCherry–FRB–emerin, with staining in
ER regions, and at the perinuclear ER and the nuclear rim. Addition
of rapamycin, however, did not result in a redistribution of nuclear
GFP2–GST–NLS–FKBP12, suggesting that WRB-FRB-HA is
restricted to the ER and the ONM and absent from the INM
(Fig. 8B).
Next, we used this assay to analyze INM-targeting of wild-type
and mutant forms of emerin (Fig. 8C). For a better comparison of
targeting efficiencies (Fig. 8D), the GFP2–GST–NLS–FKBP12
signal at the INM in rapamycin-treated cells was scored as ‘+++’,
‘++’, ‘+’ and ‘−’ (see legend for details). The two mutants lacking a
transmembrane domain, mCherry–FRB–emerin-Trp226* and
-Leu225Arg-FS (Fig. 6A,B), localized to the nucleus, in
agreement with previous studies, where similar constructs had
been used (Östlund et al., 1999; Tsuchiya et al., 1999).
Consequently, rapamycin did not induce a relocalization of the
GFP reporter protein to the nuclear periphery – instead, this
depended on the presence of an FRB-presenting protein at the INM
(Fig. 8B). The deletion mutant mCherry–FRB–emerin-ΔVal236-
Phe241 was mostly found in aggregates throughout the cell and the
co-expressed GFP reporter was not sequestered at the nuclear rim in
the presence of rapamycin. The point mutants mCherry–FRB–
emerin-Pro183Thr, -Pro183His and -Gln228His, which all
localized to the nuclear rim as HA fusion proteins in a very
similar fashion to wild-type emerin (see Fig. 7), also showed a
similar mCherry signal to the corresponding wild-type protein
(Fig. 8C). Accordingly, rapamycin induced recruitment of the GFP
reporter to the INM, albeit to a lower extent compared to cells
that had been co-transfected with wild-type mCherry–FRB-emerin
(‘++’ versus ‘+++’). Strikingly, reduced INM targeting was even
more obvious for the frame shift mutant mCherry–FRB–emerin-
Phe240His-FS, which also showed a very prominent localization at
the nuclear rim as an HA-tagged protein, irrespective of the
permeabilization method (Fig. 7). Here, the effect of the rapamycin
treatment was rather variable: in many cells (56%, 100 cells
analyzed), rapamycin did not induce relocalization of GFP2–GST–
NLS–FKBP12 to the nuclear rim at all. In others, the effect was
rather subtle compared to cells expressing wild-type mCherry–
FRB–emerin, demonstrating that targeting to the INM was clearly
impaired for this emerin mutant.
Thus, transport of emerin to or its retention at the INM depends
on crucial features of the transmembrane domain or the luminal
C-terminus and, potentially, on additional single amino acid
residues in its close proximity. The assay shows that all disease
mutants investigated reduce the fidelity with which emerin reaches
its final destination, the INM. Localization at the nuclear rim, as
observed for emerin mutants in previous studies (Fairley et al.,
1999; Lee et al., 2001) is clearly not equivalent to correct targeting
to the INM.
DISCUSSION
In this study, we analyzed membrane insertion and targeting of
emerin to the INM and several clinically relevant emerin mutants
linked to EDMD. The TRC40 pathway is the most prominent route
for post-translational membrane integration of tail-anchored
proteins, although other pathways that are promoted by HSC70 or
HSP40 (Rabu et al., 2008) or the SRP (Abell et al., 2004, 2007) have
been described. Furthermore, membrane insertion can occur
through unassisted pathways that do not depend on additional
soluble and/or membrane-bound factors (Brambillasca et al., 2006;
Colombo et al., 2009). Upon co-expression in bacteria, emerin and
TRC40 formed a stable complex (Fig. 1B), suggesting that emerin
can also be captured by TRC40 as soon as it emerges from the
translating ribosome in eukaryotic cells. Accordingly, depletion of
TRC40 from reticulocyte lysates resulted in a clearly reduced
membrane insertion of emerin (Fig. 2C). Given that the interaction
of tail-anchored proteins with components of the TRC40 machinery
is rather transient, it has been difficult to detect by classical co-
immunoprecipitation approaches. However, PLAs corroborated
our findings, showing that endogenous emerin interacts with
overexpressed TRC40, albeit with lower signal numbers than
endogenous Sec61β. In this assay, the number of dots that are scored
as single interaction sites depends on (among other factors)
the abundance of the individual proteins and on the quality of the
specific antibodies. Hence, a quantitative comparison of the
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Fig. 8. Mutations in the emerin gene affect targeting to the INM. (A) Rapamycin assay. Upon rapamycin (R) treatment, the soluble nuclear EGFP2–GST–NLS–
FKBP12 reporter is recruited to mCherry–FRB–emerin at the INM. (B,C) HeLa cells were co-transfected with constructs coding for EGFP2–GST–NLS–FKBP12
(GFP-GST-NLS) and WRB–FRB–HA (WRB; B) or variants of mCherry–FRB–emerin (emerin; B,C), permeabilized with digitonin and treated with (+) or
without (−) rapamycin. WT, wild-type. After fixation, cells were analyzed by confocal microscopy, either directly (emerin) or after immunostaining (WRB-FRB-HA).
Scale bars, 15 µm. Typical cells at higher magnification (+ rapamycin) are shown in the inserts. Note that under our assay conditions (10 min on ice), the GFP
reporter protein does not exit from the nucleus. (D) Semi-quantitative analysis of the rapamycin-effect on EGFP2–GST–NLS-FKBP12. +++, clear rim in essentially
all cells; ++, visible rim in most cells but residual nuclear signal; +, visible rim in some cells, signal mostly nuclear; and −, no nuclear rim). Between 20 (Trp226*)
and 100 cells (WT, Phe240His-FS) from separate experiments were scored.
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interaction of the two tail-anchored proteins with TRC40 is not
possible. Nevertheless, for Sec61β as well as for emerin, the signals
were specific and almost exclusively detected in the cytoplasmic
region of the cells, consistent with interactions occurring at or close
to ER membranes. PLAs have been used previously for the
detection of TRC40 binding to tail-anchored proteins (Hradsky
et al., 2011), but, to our knowledge, only upon overexpression of
both interacting partners. Here, we used antibodies against
endogenous emerin to monitor binding to lamin A/C as well as
Myc-tagged TRC40. Hence, this assay should be applicable for the
analysis of interactions between other tail-anchored proteins and
TRC40 or other components of the TRC40 machinery.
Our integration assays using microsomes (Figs 1, 2 and 6) or
permeabilized cells (Fig. 3) clearly confirmed the possibility of
post-translational membrane insertion of opsin-tagged emerin in a
TRC40-, WRB- and CAML-assisted manner. The permeabilized
cell system should be useful for future approaches, e.g. for analysis
of membrane insertion upon knockdown of certain components of
the TRC40 machinery. Our in vivo experiments with TRC40-
depleted cells (Fig. 5) further strengthen these findings. Of course,
we cannot rule out the possibility that in cells lacking TRC40,
membrane insertion of emerin is supported by alternative post-
translational mechanisms. In summary, we provide experimental
evidence for emerin as the first tail-anchored protein of the INM that
uses the TRC40 pathway for membrane insertion.
Several studies have analyzed the role of specific properties of
individual transmembrane domains as well as of neighboring
regions on post-translational membrane insertion of tail-anchored
proteins (Beilharz et al., 2003; Borgese et al., 2001). As expected,
emerin mutants with a complete loss of (Trp226*) or with
drastic changes within the transmembrane domain (Leu225Arg-FS,
ΔVal236-Phe241, Phe240His-FS) showed strongly reduced
binding to TRC40 (Fig. 6C) and impaired membrane insertion
in the microsome assay (Fig. 6C,D). Accordingly, HA-tagged
emerin-Trp226*, -Leu225Arg-FS and -ΔVal236-Phe241 did not
show a prominent localization at the nuclear envelope in transfection
experiments (Fig. 7). Surprisingly, however, HA–emerin-
Phe240His-FS was found at the nuclear rim, very similar to the
wild-type protein, although it showed strongly reduced insertion
efficiency into ER-derived microsomes (Fig. 6D,E). Perhaps this
mutant with its shortened transmembrane domain and a less negative
ΔG-value formembrane insertion (−1.791 compared to−4.288 kcal/
mol for wild-type emerin) is able to insert into the cellular membrane
system in an unassistedmanner or with the help of certain chaperones
that are present in intact cells but not in the microsome assay. Similar
results have been described for protein tyrosine phosphatase 1B,
whose transmembrane domain is less hydrophobic than that of
emerin (Brambillasca et al., 2006). Similarly, the emerin mutants
Pro183Thr and Pro183His showed slightly reduced binding to
TRC40 and significantly reduced membrane insertion (Fig. 6C,D),
yet the localization of HA-tagged proteins appeared normal (Fig. 7).
The transmembrane domains of these mutants are identical to that of
wild-type emerin, suggesting that residues upstream of the
hydrophobic stretch can affect the interaction with TRC40. For the
corresponding GFP-tagged emerin mutants, reduced levels of
fluorescence at the nuclear rim have been described previously
(Fairley et al., 1999). Correct targeting to the INM, as opposed to
the ONM was, however, not analyzed in that study. Our
immunofluorescence results after differential permeabilization
(Fig. 7) and the results of the rapamycin assay (Fig. 8C,D) now
suggest that the emerin-Pro183 mutants and, in particular, the
Phe240His-FSmutant have impaired targeting to the INM, although,
at the level of light microscopy, their localization pattern at the
nuclear envelope was similar to that of the wild-type protein.
The exact route of emerin (or other proteins of the INM) from the
ER via the ONM and the NPC to the INM is not known. With
respect to molecular mechanisms, two very recent publications
(Boni et al., 2015; Ungricht et al., 2015) have shown that passive
diffusion followed by subsequent retention at the target site are
major determinants of INM localization. Nevertheless, energy-
dependent changes in ERmorphology have been suggested to affect
the transport rates of proteins to the INM (Ungricht et al., 2015) and
are also expected to affect proteins that are post-translationally
inserted into the ERmembrane. Selected proteins, by contrast, seem
to require more active, transport-factor-dependent mechanisms
(Laba et al., 2015). Transmembrane proteins that are co-
translationally inserted into the ER membrane must passage
through the NPCs in a membrane-bound form, possibly through
dedicated, peripheral channels (Maimon et al., 2012). For tail-
anchored proteins, it is principally possible that they are imported
into the nucleus as soluble complexes with TRC40, followed by
direct insertion into the INM from within the nuclear interior. In
light of the low nuclear levels of TRC40 (Fig. 4C), the rather few
PLA signals revealing emerin–TRC40 interactions inside the
nucleus (Fig. 4C) and the apparent absence of the receptor protein
WRB from the INM (Fig. 8B), this route seems rather unlikely.
Instead, emerin is probably inserted into the ER system as a default
membrane for tail-anchored proteins. From the ER, it is expected to
traffic to the INM via the ONM and the NPC. Emerin as well as
several other proteins of the INM contain putative nuclear
localization signals (NLSs) and emerin fragments lacking the
transmembrane domain were found to accumulate in the nucleus as
a result of the NLS activity (Östlund et al., 1999; Tsuchiya et al.,
1999). The significance of these NLSs and also of their cognate
receptor proteins (e.g. importin α and β) for trafficking of
membrane-bound proteins across the NPC, however, remains
unclear.
In intact cells, the different mutant emerin variants that we tested
reached the INM with efficiencies that cannot entirely be predicted
by the efficiency of membrane insertion into microsomes. Thus, our
results might suggest that membrane insertion of emerin through the
TRC40 pathway and trafficking of the protein to the INM are
sequential processes with distinct requirements. However, the major
determinants for proper localization of emerin to the INM have been
localized to regions outside of the transmembrane domain (Östlund
et al., 1999; Tsuchiya et al., 1999). Our observations thus raise the
interesting possibility that integration through the TRC40 pathway
affects the correct targeting of emerin to its final destination, beyond
initial membrane insertion. Perhaps the emerin mutant Phe240His-
FS reaches the ONM by an alternative pathway that is not
compatible with probing the INM and its constituent proteins. In
summary, the molecular pathogenesis of EDMD as caused by the
different mutations is likely to be complex. Damaging effects might
result from reduced levels of functional emerin in the INM or from
toxicity caused by mislocalized emerin variants. Given that
interaction with nuclear proteins is key to emerin functions
(Demmerle et al., 2012), mislocalization to the ONM or the ER is
expected to contribute to the pathologic phenotypes of certain
emerin mutants. Furthermore, mislocalization of tail-anchored
proteins to the outer membrane of mitochondria has been
recognized as a potential mechanism of toxicity in yeast and
mammalian cells (Chen et al., 2014; Okreglak and Walter, 2014;
Schuldiner et al., 2008). It will be necessary to consider these
different possible causes of disease when further elucidating the
512












targeting of wild-type emerin and its mutant variants in the pertinent
differentiated cells, like skeletal muscle cells or cardiomyocytes.
MATERIALS AND METHODS
Plasmids and constructs
All constructs were obtained using standard methods and verified
by sequencing. The vector for coexpression of MBP–TRC40 and an
HZZ-tagged tail-anchored protein was as described previously (Favaloro
et al., 2010). Briefly, the coding sequence of human emerin was amplified
by PCR using emerin–GFP (obtained from Eric Schirmer, Edinburgh, UK)
as a template and forward (5′-TTTGGTACCACCATGGACAACTACGC-
AGATCTT-3′) and reverse (5′-CAAGCTTTATCAGCCCGTCTTGTTG-
GAGAAAGGCACGTAGAAGTTTGGGCCGAAGGGGTTGCCTTCTT-
CAG-3′) primers, the latter also coding for an opsin tag. The PCR-product
was cloned into a modified pET-vector (pET328) through KpnI and
HindIII, generating a fusion construct with an N-terminal HZZ tag
(pET328-HZZ-Emerin-opsin). The modified emerin-sequence was then
cut with AvrII and NheI and cloned into a pQE80-vector that also codes for
MBP–TRC40, generating pQE80-MBP-TRC40/HZZ-emerin-opsin. For
pEF-HA-emerin, the emerin coding sequence was amplified from
emerin–GFP and cloned into pEF-HA (Gasteier et al., 2003) through SpeI
and NcoI. To generate pGEM3Z-Emerin-opsin, a KpnI–HindIII fragment
from pET328-HZZ-Emerin-opsin was cloned into pGEM3Z.
Emerin mutants Pro183His, Pro183Thr, Leu225Arg-FS, Trp226*,
Gln228His, ΔVal236-Phe241 and Phe240His-FS were generated in
pQE80-MBP-TRC40/HZZ-emerin-opsin and in pEF-HA-emerin by
Quikchange site-directed mutagenesis (Braman et al., 1996) or SPRINP
methods (Edelheit et al., 2009), using appropriate oligonucleotides (list
available upon request).
The FKBP12 sequence for the plasmid coding for EGFP2–GST–NLS–
FKBP12 was obtained by PCR amplification from pcDNA3-FKBP12
(Belshaw et al., 1996) and inserted into a pEGFP-C1-derivative coding for
EGFP2–GST–NLS (kindly provided by Detlef Doenecke, Göttingen,
Germany) through BamHI and XbaI.
Human FRB (the minimal FKBP12-rapamycin-binding domain from
FRAP, 2025–2114 fragment; Chen et al., 1995) was PCR amplified from
CD4-FRAP-pcDNA3 and cloned into pmCherry-C1 (Clontech) through
BglII and XhoI, generating pmCherry-FRB. The emerin sequence was then
introduced through XhoI and BamH1, generating pmCherry-FRB-emerin.
Emerin mutants as above were amplified from pEF-HA-emerin mutant
vectors and cloned into pmCherry-FRB through XhoI and BamHI. The
point mutation pmCherry-FRB-emerin Gln228His was generated by
Quikchange mutagenesis in pmCherry-FRB-emerin-WT. To obtain
pcDNA-WRB-FRB-HA, the sequences for human WRB and FRB were
PCR-amplified from pRK5-WRB-HA (Vilardi et al., 2011) and pmCherry-
FRB and cloned through NheI-HindIII or HindIII-BamHI, respectively, into
a pcDNA3.1(+) derivative containing an HA tag.
Expression and purification of proteins
Recombinant MBP-TRC40/HZZ-emerin variant complexes were obtained
as described previously (Favaloro et al., 2010) with some modifications.
E. coli BL21AI cells were transformed with pQE80-MBP-TRC40/HZZ-
emerin-opsin variants. Expression of MBP–TRC40 was induced at an
optical density at 600 nm (OD600) of 0.5 with 50 μM IPTG for 1 h at 30°C,
followed by induction of HZZ–emerin expression with 0.25% arabinose for
4 h. Cells were harvested and lysed by sonification in cold LS buffer
(50 mM Hepes, 150 mM potassium acetate, 5 mM Mg(OAc)2, 10%
glycerol, 1 mM PMSF, 1 mM DTT, pH 7.0) supplemented with 20 mM
imidazole and 10 μg/ml DNase I. The lysate was cleared at 100,000 g for
30 min and incubated with a Ni-NTA resin. After 1 h, the resin was
sequentially washed with LS buffer supplemented with 5 mM ATP, HS
buffer (50 mM Hepes, 500 mM KOAc, 5 mM Mg(OAc)2, 10% glycerol,
1 mM PMSF, 1 mM DTT, pH 7.0) and LS buffer. All washing buffers were
supplemented with 20 mM imidazole. The proteins were eluted with LS
buffer containing 300 mM imidazole and incubated with an amylose resin
for 1 h. The resin was washed with LS buffer supplemented with 5 mM
ATP, with HS buffer and again with LS buffer, and the recombinant
complex was eluted with LS buffer containing 20 mM maltose.
Expression of the terminal cytosolic domain of CAML (GST–CAML-N)
(Yamamoto and Sakisaka, 2012) and of the coiled-coil domain of WRB
(MBP–WRBcc) (Vilardi et al., 2011) was as described previously.
Cell culture, transfections and immunofluorescencemicroscopy
HeLa P4 cells (Charneau et al., 1994), were obtained from the NIH AIDS
Reagent Program and were grown in DMEM (Gibco) supplemented with
10% (v/v) FCS (Gibco), 100 U/ml penicillin, 100 μg/ml streptomycin, and
2 mM L-glutamine (Gibco) under 5% CO2 at 37°C. They were tested for
contamination by mycoplasma on a regular basis. For immunofluorescence,
cells were grown on poly-L-lysine-coated coverslips and transfected with
the calcium phosphate method (Chen and Okayama, 1987) unless specified
otherwise. For siRNA-mediated knockdown, cells were transfected with
Lipofectamine (Invitrogen) for 48 h according to manufacturer’s
instructions using siRNAs against TRC40 (s1675, Ambion) or a non-
targeting control siRNA (AM4635, Ambion).
Cells were fixed with 3.7% (v/v) formaldehyde in PBS and permeabilized
with 0.5% Triton X-100 in PBS for 5 min on ice, except for the differential
permeabilization experiments. Samples were blocked with either 2% BSA
or 10% FCS in PBS for 30 min and incubated with primary antibodies
diluted in blocking buffer for 1.5 h at room temperature. Incubation with
secondary antibodies was performed for 1 h in blocking buffer at room
temperature. In siRNA experiments, cells were fixed in 100% methanol at
−20°C for 5 min.
Cells were mounted with Mowiol-DAPI and analyzed using an Axiovert
200 M fluorescence microscope with a 63× Plan-Neofluar 1.3 NA water-
corrected objective and appropriate filter settings. Images were taken using
an LSM 510-META confocal laser scanning microscope (Zeiss) and
processed using ImageJ and Adobe Photoshop 6.0.
For quantification of the knockdown effects on the fluorescent signal, a
small circle was drawn at the nuclear envelope or in the cytoplasm and
fluorescence intensities were determined after background subtraction.
Averages were calculated for each treatment group and plotted relative to the
highest value (control siRNA), which was set to 100%.
Antibodies and western blotting
For immunodepletions, rat monoclonal anti-HSC70 (1:1000, Stressgen) and
rabbit anti-TRC40 (Favaloro et al., 2010) antibodies were used. For indirect
immunofluorescence, mouse anti-HA antibodies (1:1000, Convance or
Sigma), mouse-anti-TRC40 (1:200, Sigma), rabbit anti-emerin (1:300,
Proteintech), rabbit-anti-LBR (1:300, Proteintech), rabbit-anti-STT3B (kind
gift from Stephen High, Manchester) and anti-lamin A/C (1:200, Abcam)
were used as primary antibodies and donkey-anti-mouse-IgG conjugated to
Alexa Fluor 488 or 594 (1:1000; Molecular Probes) as secondary antibodies.
Mouse anti-opsin (Adamus et al., 1991), rabbit anti-calnexin (1:1000, Enzo),
rabbit-anti-TRC40 (1:1000, Proteintech) and rabbit-anti emerin (1:1000,
Santa Cruz Biotechnology) antibodies were used for immunoblotting. For
the PLA, mouse anti-myc (1:1000; Santa Cruz Biotechnology), rabbit anti-
emerin (1:2000, Proteintech), rabbit anti-Sec61β (kind gift from Bernhard
Dobberstein, Heidelberg), rabbit anti-STT3B or mouse anti-lamin A/C
(1:1000, Abcam) antibodies were used. Western blotting was performed
according to standard methods using the Odyssey system (Licor) for
secondary antibody detection. For siRNA experiments, chemiluminescence
(Millipore) was used. Statistical significance of the data was analyzed by a
two-tailed Student’s t-test.P<0.05was considered as biologically significant.
Microsome integration assay
Membrane integration of emerin variants was evaluated as previously
described (Favaloro et al., 2010;Vilardi et al., 2011). Briefly, two equivalents
of rough microsomes (Walter and Blobel, 1983) were incubated for 1 h at
30°C with 200 ng of HZZ–emerin–opsin and MBP–TRC40 complexes in a
final volume of 20 µl in the absence or presence of 1 mM ATP.
Where indicated, MBP–WRB coiled-coil domain (MBP-WRBcc) or the
GST–CAML-N terminal cytosolic domain (GST-CAML-N) were added to
a final concentration of 10 μM. In some experiments, glycosylation or
phosphorylation of opsin-tagged emerin was confirmed by treatment of the
samples with either 1000 units of EndoH (New England Biolabs), or 400
units of lambda phosphatase (New England Biolabs), in a final volume of
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40 µl, according to the instructions of the manufacturer. The efficiency of
membrane integration was monitored by SDS-PAGE, followed by western
blotting and signal detection using the Odyssey system (Licor). In order to
avoid the interference of phosphorylated emerin in the quantification of
glycosylation, lambda phosphatase treatment was carried out after the
insertion. Signals were quantified using Image Studio Lite (Licor) and
expressed as the percentage of N-glycosylated emerin compared with total
emerin. Statistical significance of the data was analyzed as above.
Membrane integration in permeabilized cells
HeLa P4 cells grown on plastic dishes were trypsinized and washed with
culture medium and PBS. 4×106 cells were resuspended in 400 µl transport
buffer [TPB; 20 mM HEPES, 110 mM KOAc, 2 mM Mg(OAc)2, 1 mM
EGTA, pH 7.3, 2 mM DTT, 0.1 mM PMSF and 1 µg/ml each of leupeptin,
pepstatin and aprotinin] and permeabilized with a final concentration of
0.01% digitonin. Cells were washed three times with TPB and resuspended
in TPB at 10,000 cells/µl. In a reaction volume of 100 µl, 200,000 cells were
incubated with 200 ng of the MBP–TRC40 and HZZ–emerin-WT complex
and 1 mM lithium-ATP (Roche) for 1 h at 30°C, followed by centrifugation
at 16,000 g for 20 min. After one washing step with TPB, the cells were
dissolved in SDS sample buffer and subjected to SDS-PAGE and
immunoblotting. For deglycosylation, cells were treated with 500 units
PNGaseF (NEB) in a 20 μl reaction after membrane integration.
Proximity ligation assay
HeLa cells were transfected with a plasmid coding for TRC40-myc using
Lipofectamine 2000 (Invitrogen). At 48 h post transfection, cells were fixed
and permeabilized as described above. Cells were then subjected to the
proximity ligation assay (PLA) using the Duolink red kit (O-link
Bioscience) in a humidity chamber according to the manufacturer’s
instructions. Briefly, cells were blocked, incubated with appropriate
primary antibodies and thereafter incubated with PLA probes, which are
secondary antibodies (anti-mouse-IgG and anti-rabbit-IgG) conjugated to
unique oligonucleotides. Samples were then treated with a ligation solution
(allowing oligonucleotide pairs in close proximity to form a closed
circle) followed by an amplification solution containing polymerase and
fluorescently labeled oligonucleotides, allowing rolling-circle amplification
and detection of discrete fluorescent dots. After the PLA protocol, cells
were counterstained with anti-Myc monoclonal antibody (Santa Cruz
Biotechnology) and Alexa-Fluor-488-conjugated (Molecular Probes)
secondary antibody to visualize TRC40–Myc transfected cells. Cells were
mounted using Duolink mounting medium with DAPI (O-link Bioscience)
and analyzed by confocal laser scanning microscopy with a 63× water
objective. 100 cells, over two independent experiments, were imaged for
analysis and each red dot was scored as a single interaction site by eye or
using the Duolink Image Tool software.
Differential permeabilization assay
HeLa cells were transfected with plasmids coding for HA-tagged emerin
variants and permeabilized either with 0.007% digitonin in TPB for 5 min
on ice prior to fixation with 3.7% formaldehyde in PBS or first fixed
and then permeabilized with 0.3% Triton X-100 and 0.05% SDS in
PBS for 10 min at room temperature. Cells were then subjected to
immunofluorescence microscopy.
Rapamycin assay
HeLa cells were grown on coverslips and transfected with plasmids coding
for EGFP2–GST–NLS–FKBP12 and an FRB-containing protein of interest.
After 24 h, they were permeabilized with 0.007% digitonin in TPB
containing protease inhibitors for 5 min on ice, washed in TPB and treated
with 200 nM rapamycin (Sigma) in TPB for 10 min on ice. Cells were
washed again with PBS, fixed with 3.7% formaldehyde in PBS and
subjected to immunofluorescence microscopy.
Coupled in vitro transcription and translation
Reactions were performed in the TnT Quick Coupled Transcription/
Translation System (Promega). Briefly, 200 ng of plasmid DNA (pGEM3Z-
Emerin-opsin) was used and the reaction was carried out for 90 min at 30°C.
25% of the reaction was separated by SDS-PAGE for immunodetection.
Immunodepletion of TRC40 or HSC70 was performed as described
previously (Johnson et al., 2012).
Acknowledgements
We are grateful to Stephen High (Manchester) and Bernhard Dobberstein
(Heidelberg) for reagents and Stephen High for very helpful discussions. We also
wish to thank Lena Musiol for critical reading of the manuscript.
Competing interests
The authors declare no competing or financial interests.
Author contributions
J.P., J.R.M., C.J., F.V., B.S and R.H.K. designed research; J.P., J.R.M., C.J., K.R.,
F.V. and R.H.K. performed research; J.P., J.R.M., C.J., K.R., F.V., B.S and R.H.K.
analyzed data; J.P., J.R.M., R.H.K. and B.S. wrote the paper.
Funding
This study was supported by grants of the Deutsche Forschungsgemeinschaft
[grant numbers KE 660/12-1 to R.H.K. and SFB1002, TP B01, to B.S.]; and by the
People Progamme (Marie Curie Actions) of the European Union’s Seventh
Framework Programme (FP7/2007-2013/) under the Research Executive Agency
[grant number 607072 to B.S. and J.R.M.].
References
Abell, B. M., Pool, M. R., Schlenker, O., Sinning, I. and High, S. (2004). Signal
recognition particle mediates post-translational targeting in eukaryotes. EMBO J.
23, 2755-2764.
Abell, B. M., Rabu, C., Leznicki, P., Young, J. C. and High, S. (2007). Post-
translational integration of tail-anchored proteins is facilitated by defined
molecular chaperones. J. Cell Sci. 120, 1743-1751.
Adamus, G., Zam, Z. S., Arendt, A., Palczewski, K., McDowell, J. H. and
Hargrave, P. A. (1991). Anti-rhodopsin monoclonal antibodies of defined
specificity: characterization and application. Vision Res. 31, 17-31.
Beilharz, T., Egan, B., Silver, P. A., Hofmann, K. and Lithgow, T. (2003). Bipartite
signals mediate subcellular targeting of tail-anchored membrane proteins in
Saccharomyces cerevisiae. J. Biol. Chem. 278, 8219-8223.
Belshaw, P. J., Ho, S. N., Crabtree, G. R. and Schreiber, S. L. (1996). Controlling
protein association and subcellular localization with a synthetic ligand that induces
heterodimerization of proteins. Proc. Natl. Acad. Sci. USA 93, 4604-4607.
Bione, S., Maestrini, E., Rivella, S., Mancini, M., Regis, S., Romeo, G. and
Toniolo, D. (1994). Identification of a novel X-linked gene responsible for Emery-
Dreifuss muscular dystrophy. Nat. Genet. 8, 323-327.
Boni, A., Politi, A. Z., Strnad, P., Xiang, W., Hossain, M. J. and Ellenberg, J.
(2015). Live imaging and modeling of inner nuclear membrane targeting reveals
its molecular requirements in mammalian cells. J. Cell Biol. 209, 705-720.
Borgese, N., Gazzoni, I., Barberi, M., Colombo, S. and Pedrazzini, E. (2001).
Targeting of a tail-anchored protein to endoplasmic reticulum and mitochondrial
outer membrane by independent but competing pathways. Mol. Biol. Cell 12,
2482-2496.
Braman, J., Papworth, C. and Greener, A. (1996). Site-directed mutagenesis
using double-stranded plasmid DNA templates. Methods Mol. Biol. 57, 31-44.
Brambillasca, S., Yabal, M., Makarow, M. and Borgese, N. (2006). Unassisted
translocation of large polypeptide domains across phospholipid bilayers. J. Cell
Biol. 175, 767-777.
Burns, L. T. andWente, S. R. (2012). Trafficking to uncharted territory of the nuclear
envelope. Curr. Opin. Cell Biol. 24, 341-349.
Cartegni, L., di Barletta, M. R., Barresi, R., Squarzoni, S., Sabatelli, P., Maraldi,
N., Mora, M., Di Blasi, C., Cornelio, F., Merlini, L. et al. (1997). Heart-specific
localization of emerin: new insights into Emery-Dreifuss muscular dystrophy.
Hum. Mol. Genet. 6, 2257-2264.
Charneau, P., Mirambeau, G., Roux, P., Paulous, S., Buc, H. and Clavel, F.
(1994). HIV-1 reverse transcription. A termination step at the center of the
genome. J. Mol. Biol. 241, 651-662.
Chen, C. and Okayama, H. (1987). High-efficiency transformation of mammalian
cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
Chen, J., Zheng, X. F., Brown, E. J. and Schreiber, S. L. (1995). Identification of an
11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-
rapamycin-associated protein and characterization of a critical serine residue.
Proc. Natl. Acad. Sci. USA 92, 4947-4951.
Chen, Y.-C., Umanah, G. K. E., Dephoure, N., Andrabi, S. A., Gygi, S. P.,
Dawson, T. M., Dawson, V. L. and Rutter, J. (2014). Msp1/ATAD1 maintains
mitochondrial function by facilitating the degradation of mislocalized tail-anchored
proteins. EMBO J. 33, 1548-1564.
514












Colombo, S. F., Longhi, R. and Borgese, N. (2009). The role of cytosolic proteins
in the insertion of tail-anchored proteins into phospholipid bilayers. J. Cell Sci. 122,
2383-2392.
Demmerle, J., Koch, A. J. andHolaska, J. M. (2012). The nuclear envelope protein
emerin binds directly to histone deacetylase 3 (HDAC3) and activates HDAC3
activity. J. Biol. Chem. 287, 22080-22088.
Edelheit, O., Hanukoglu, A. and Hanukoglu, I. (2009). Simple and efficient site-
directed mutagenesis using two single-primer reactions in parallel to generate
mutants for protein structure-function studies. BMC Biotechnol. 9, 61.
Ellis, J. A., Craxton, M., Yates, J. R. and Kendrick-Jones, J. (1998). Aberrant
intracellular targeting and cell cycle-dependent phosphorylation of emerin
contribute to the Emery-Dreifuss muscular dystrophy phenotype. J. Cell Sci.
111, 781-792.
Fairley, E. A., Kendrick-Jones, J. and Ellis, J. A. (1999). The Emery-Dreifuss
muscular dystrophy phenotype arises from aberrant targeting and binding of
emerin at the inner nuclear membrane. J. Cell Sci. 112, 2571-2582.
Favaloro, V., Spasic, M., Schwappach, B. and Dobberstein, B. (2008). Distinct
targeting pathways for the membrane insertion of tail-anchored (TA) proteins.
J. Cell Sci. 121, 1832-1840.
Favaloro, V., Vilardi, F., Schlecht, R., Mayer, M. P. and Dobberstein, B. (2010).
Asna1/TRC40-mediatedmembrane insertion of tail-anchored proteins. J. Cell Sci.
123, 1522-1530.
Foisner, R. and Gerace, L. (1993). Integral membrane proteins of the nuclear
envelope interact with lamins and chromosomes, and binding is modulated by
mitotic phosphorylation. Cell 73, 1267-1279.
Furukawa, K., Pante, N., Aebi, U. and Gerace, L. (1995). Cloning of a cDNA for
lamina-associated polypeptide 2 (LAP2) and identification of regions that specify
targeting to the nuclear envelope. EMBO J. 14, 1626-1636.
Gasteier, J. E., Madrid, R., Krautkrämer, E., Schröder, S., Muranyi, W.,
Benichou, S. and Fackler, O. T. (2003). Activation of the Rac-binding partner
FHOD1 induces actin stress fibers via a ROCK-dependent mechanism. J. Biol.
Chem. 278, 38902-38912.
Hegde, R. S. and Keenan, R. J. (2011). Tail-anchored membrane protein insertion
into the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 12, 787-798.
Hessa, T., Meindl-Beinker, N. M., Bernsel, A., Kim, H., Sato, Y., Lerch-Bader, M.,
Nilsson, I., White, S. H. and von Heijne, G. (2007). Molecular code for
transmembrane-helix recognition by the Sec61 translocon. Nature 450,
1026-1030.
Hradsky, J., Raghuram, V., Reddy, P. P., Navarro, G., Hupe, M., Casado, V.,
McCormick, P. J., Sharma, Y., Kreutz, M. R. and Mikhaylova, M. (2011). Post-
translational membrane insertion of tail-anchored transmembrane EF-hand Ca2+
sensor calneurons requires the TRC40/Asna1 protein chaperone. J. Biol. Chem.
286, 36762-36776.
Johnson, N., Vilardi, F., Lang, S., Leznicki, P., Zimmermann, R. and High, S.
(2012). TRC40 can deliver short secretory proteins to the Sec61 translocon.
J. Cell Sci. 125, 3612-3620.
Kalbfleisch, T., Cambon, A. and Wattenberg, B. W. (2007). A bioinformatics
approach to identifying tail-anchored proteins in the human genome. Traffic 8,
1687-1694.
King, M. C., Patrick Lusk, C. and Blobel, G. (2006). Karyopherin-mediated import
of integral inner nuclear membrane proteins. Nature 442, 1003-1007.
Korfali, N., Wilkie, G. S., Swanson, S. K., Srsen, V., de las Heras, J., Batrakou,
D. G., Malik, P., Zuleger, N., Kerr, A. R.W., Florens, L. et al. (2012). The nuclear
envelope proteome differs notably between tissues. Nucleus 3, 552-564.
Kralt, A., Jagalur, N. B., van den Boom, V., Lokareddy, R. K., Steen, A.,
Cingolani, G., Fornerod, M. and Veenhoff, L. M. (2015). Conservation of inner
nuclear membrane targeting sequences in mammalian Pom121 and yeast Heh2
membrane proteins. Mol. Biol. Cell 26, 3301-3312.
Kutay, U., Hartmann, E. and Rapoport, T. A. (1993). A class of membrane proteins
with a C-terminal anchor. Trends Cell Biol. 3, 72-75.
Laba, J. K., Steen, A. and Veenhoff, L. M. (2014). Traffic to the inner membrane of
the nuclear envelope. Curr. Opin. Cell Biol. 28, 36-45.
Laba, J. K., Steen, A., Popken, P., Chernova, A., Poolman, B. and Veenhoff,
L. M. (2015). Active nuclear import of membrane proteins revisited. Cells 4,
653-673.
Leach, N., Bjerke, S. L., Christensen, D. K., Bouchard, J. M., Mou, F., Park, R.,
Baines, J., Haraguchi, T. and Roller, R. J. (2007). Emerin is
hyperphosphorylated and redistributed in herpes simplex virus type 1-infected
cells in a manner dependent on both UL34 and US3. J. Virol. 81, 10792-10803.
Lee, K. K., Haraguchi, T., Lee, R. S., Koujin, T., Hiraoka, Y. and Wilson, K. L.
(2001). Distinct functional domains in emerin bind lamin A and DNA-bridging
protein BAF. J. Cell Sci. 114, 4567-4573.
Leznicki, P., Clancy, A., Schwappach, B. and High, S. (2010). Bat3 promotes the
membrane integration of tail-anchored proteins. J. Cell Sci. 123, 2170-2178.
Lin, F., Blake, D. L., Callebaut, I., Skerjanc, I. S., Holmer, L., McBurney, M. W.,
Paulin-Levasseur, M. and Worman, H. J. (2000). MAN1, an inner nuclear
membrane protein that shares the LEM domain with lamina-associated
polypeptide 2 and emerin. J. Biol. Chem. 275, 4840-4847.
Maimon, T., Elad, N., Dahan, I. and Medalia, O. (2012). The human nuclear pore
complex as revealed by cryo-electron tomography. Structure 20, 998-1006.
Manilal, S., Man, N. t. and Morris, G. E. (1998a). Colocalization of emerin and
lamins in interphase nuclei and changes during mitosis. Biochem. Biophys. Res.
Commun. 249, 643-647.
Manilal, S., Recan, D., Sewry, C. A., Hoeltzenbein, M., Llense, S., Leturcq, F.,
Deburgrave, N., Barbot, J.-C., Man, N., Muntoni, F. et al. (1998b). Mutations in
Emery-Dreifuss muscular dystrophy and their effects on emerin protein
expression. Hum. Mol. Genet. 7, 855-864.
Mariappan, M., Li, X., Stefanovic, S., Sharma, A., Mateja, A., Keenan, R. J. and
Hegde, R. S. (2010). A ribosome-associating factor chaperones tail-anchored
membrane proteins. Nature 466, 1120-1124.
Mateja, A., Paduch, M., Chang, H.-Y., Szydlowska, A., Kossiakoff, A. A., Hegde,
R. S. and Keenan, R. J. (2015). Protein targeting. Structure of the Get3 targeting
factor in complex with its membrane protein cargo. Science 347, 1152-1155.
Mora, M., Cartegni, L., Di Blasi, C., Barresi, R., Bione, S., di Barletta, M. R.,
Morandi, L., Merlini, L., Nigro, V., Politano, L. et al. (1997). X-linked Emery-
Dreifuss muscular dystrophy can be diagnosed from skin biopsy or blood sample.
Ann. Neurol. 42, 249-253.
Nagano, A., Koga, R., Ogawa, M., Kurano, Y., Kawada, J., Okada, R., Hayashi,
Y. K., Tsukahara, T. and Arahata, K. (1996). Emerin deficiency at the nuclear
membrane in patients with Emery-Dreifuss muscular dystrophy. Nat. Genet. 12,
254-259.
Nigro, V., Bruni, P., Ciccodicola, A., Polltano, L., Nigro, G., Piluso, G., Cappa, V.,
Covone, A. E., Romeo, G. and D’Urso, M. (1995). SSCP detection of novel
mutations in patients with Emery-Dreifuss muscular dystrophy: definition of a
small C-terminal region required for emerin function. Hum. Mol. Genet. 4,
2003-2004.
Ognibene, A., Sabatelli, P., Petrini, S., Squarzoni, S., Riccio, M., Santi, S.,
Villanova, M., Palmeri, S., Merlini, L. and Maraldi, N. M. (1999). Nuclear
changes in a case of X-linked Emery-Dreifuss muscular dystrophy.Muscle Nerve
22, 864-869.
Ohba, T., Schirmer, E. C., Nishimoto, T. and Gerace, L. (2004). Energy- and
temperature-dependent transport of integral proteins to the inner nuclear
membrane via the nuclear pore. J. Cell Biol. 167, 1051-1062.
Okreglak, V. and Walter, P. (2014). The conserved AAA-ATPase Msp1 confers
organelle specificity to tail-anchored proteins. Proc. Natl. Acad. Sci. USA 111,
8019-8024.
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Mice lacking WRB reveal differential 
biogenesis requirements of tail-
anchored proteins in vivo
Jhon Rivera-Monroy1,*, Lena Musiol1,*, Kirsten Unthan-Fechner1, Ákos Farkas1, Anne Clancy1, 
Javier Coy-Vergara1, Uri Weill2, Sarah Gockel3, Shuh-Yow Lin4,†, David P. Corey4, Tobias Kohl3, 
Philipp Ströbel5, Maya Schuldiner2, Blanche Schwappach1,6 & Fabio Vilardi1
Tail-anchored (TA) proteins are post-translationally inserted into membranes. The TRC40 pathway 
targets TA proteins to the endoplasmic reticulum via a receptor comprised of WRB and CAML. TRC40 
pathway clients have been identified using in vitro assays, however, the relevance of the TRC40 
pathway in vivo remains unknown. We followed the fate of TA proteins in two tissue-specific WRB 
knockout mouse models and found that their dependence on the TRC40 pathway in vitro did not predict 
their reaction to receptor depletion in vivo. The SNARE syntaxin 5 (Stx5) was extremely sensitive 
to disruption of the TRC40 pathway. Screening yeast TA proteins with mammalian homologues, we 
show that the particular sensitivity of Stx5 is conserved, possibly due to aggregation propensity of its 
cytoplasmic domain. We establish that Stx5 is an autophagy target that is inefficiently membrane-
targeted by alternative pathways. Our results highlight an intimate relationship between the TRC40 
pathway and cellular proteostasis.
The need to target proteins to membranes is a consequence of cellular compartmentalization and thus a funda-
mental process in all cells. Malleable model organisms such as yeast and reductionist in vitro approaches have 
enabled the elucidation of the basic mechanisms of membrane targeting. Tail-anchored (TA) membrane proteins 
were recognized1 as a type of precursor protein with specific post-translational targeting requirements due to 
their topology. They represent a subclass of type-II oriented integral membrane proteins with a single trans-
membrane domain (TMD) at the extreme C-terminus2. In-vitro studies identified the cytosolic ATPase TRC40 
(Transmembrane domain Recognition Complex 40 kDa) as the targeting factor for TA proteins inserted into 
the membrane of the endoplasmic reticulum (ER) of higher eukaryotes3,4. A pre-targeting complex including 
the proteins BAG6, TRC35, and UBL4A receives newly synthesized TA proteins from the ribosome and trans-
fers them to the cytosolic ATPase TRC405. BAG6 also actively promotes degradation of mislocalized proteins 
by targeting them to the ubiquitin-proteasome system6,7. TRC40 delivers TA proteins to a receptor formed by 
WRB (Tryptophan Rich Basic protein)8 and CAML (Calcium signal-modulating cyclophilin ligand)9, two integral 
membrane proteins localized at the ER.
A conserved pathway in yeast features Get3, the orthologue of TRC40, and a membrane receptor complex 
comprised of the proteins Get1 and Get2 as key components10. This receptor is thought to work as an insertase for 
TA proteins at the ER membrane11. Many aspects of the molecular mechanism of TRC40/Get3-mediated inser-
tion of TA proteins have been dissected. This dissection gave rise to the current model of TRC40/Get3-dependent 
targeting that is supported by numerous structural studies of the main components of the pathway in different 
functional states12–16.
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However, the physiological client spectrum of the TRC40 pathway remains to be identified. In fact, a direct 
role of the pathway was tested for only a few of the several hundreds theoretically predicted TA proteins17 based 
on in vitro membrane integration assays3,4,18. Moreover, yeast Get3 is thought to contribute to the targeting of 
GPI-anchored proteins19 and can work as an ATP-independent chaperone under oxidative stress20. The latter 
observation positions the TRC40/Get pathway at the interface of protein biogenesis and quality control. While 
both processes make use of fundamental mechanisms that require biochemical and biophysical dissection, their 
physiological bearing and potential contribution to disease development can only be elucidated in the context of 
differentiated cell types. Insight into the role of the TRC40 pathway in the context of tissue physiology is currently 
limited.
Although the GET genes are not essential in yeast10, loss of the TRC4021 or CAML-encoding22 genes result in 
early embryonic lethality in a murine model. Generation of conditional knockouts restricted to specific cell types 
allows the identification of relevant functions of components of the TRC40 pathway in tissue development and 
physiology. A recent study revealed that pancreatic beta cells lacking TRC40 show impaired insulin secretion23, 
whereas CAML is required for thymocyte development24, and loss of either receptor subunit in inner ear cells 
causes deafness25,26.
The locus of the WRB gene (alternatively named CHD5) was mapped to the congenital heart disease region 
of human chromosome 2127. A recent study showed increased expression of WRB in Down Syndrome (DS) fetal 
fibroblasts, in accordance with the presence of an extra copy of the WRB allele28. However, a potential correlation 
between overexpression of WRB and the higher incidence of congenital heart disease in DS patients27 remains 
unclear. Knockdown of WRB in medaka fish leads to defects in cardiac development and ocular abnormalities29. 
Similarly, loss of WRB in Xenopus laevis has a strong impact on cardiac morphology and secretion of basement 
membrane matrix30. Other studies have identified an essential function of WRB in the formation of synaptic 
structures in photoreceptors and in inner ear cells26,31,32. Due to the physiological focus on the analysis of the phe-
notypes, i.e. seeing and hearing deficits, and due to the difficulties in analysing inner hair cells and photoreceptor 
cells biochemically, these studies provide limited information on the general impact of WRB loss on TA protein 
biogenesis.
Here, we follow the fate of a subset of TA proteins in two terminally differentiated cell types, cardiomyocytes 
and hepatocytes, lacking WRB. Our results indicate that the TRC40 pathway is not only active in the targeting 
and membrane insertion of TA proteins but also part of the proteostatic network with effects on the maintenance 
and quality control of the cellular proteome.
Results
Experimental Strategy. To investigate the role of the TRC40 pathway in tissue physiology, we employed 
a previously established mouse line with loxP recombination sites introduced into the WRB allele26 allowing 
tissue-specific knockouts upon crossing with mouse lines expressing the Cre recombinase under the control of 
a promoter of interest. We created tissue-specific knockout models using Cre lines leading to WRB knockout in 
adult cardiomyocytes or hepatocytes. These target cells were chosen for the potential relevance of WRB function 
to their physiology and to disease development. The gene encoding WRB was mapped to human chromosome 
21 and is associated with congenital heart disease in Down syndrome patients27 and severe cardiac developmen-
tal disorders in medaka fish29 and Xenopus laevis30. Hepatocytes are active secretory cells and therefore require 
extensive protein targeting.
Knockout of WRB in adult cardiomyocytes results in a TRC40 pathway ko. We crossed the mouse 
line carrying loxP recombination sites flanking exons 2 and 4 of the WRB gene26 with a line expressing a Cre 
recombinase fused to parts of the estrogen receptor (MerCreMer), under control of the cardiomyocyte-specific 
myosin 6 (Mhy6) promoter33. Tamoxifen injection induces nuclear translocation of the recombinase and there-
fore allowed WRB depletion in a tissue-specific and temporally controlled manner34 (Fig. 1a). Two weeks after 
tamoxifen administration, we isolated cardiomyocytes using the Langendorff perfusion method35. Quantitative 
PCR showed a strong decrease of WRB mRNA in knockout cells whereas transcript levels of TRC40 and CAML 
were unchanged (Fig. 1b). Western blot analysis confirmed a strong reduction of WRB protein level but also of 
CAML and TRC40 (Fig. 1c,d). Interdependence of receptor subunit stability was previously reported for the yeast 
GET receptor (Get1 and Get2)10 as well as for WRB and CAML36. A recent study has shown that down-regulation 
of CAML destabilizes WRB mRNA rather than the protein itself 28. However, an effect of WRB knockout on 
CAML mRNA was not observed in our system suggesting that when WRB is missing the major effect is on turn-
over of the CAML protein.
The analysis of populations of isolated cardiomyocytes revealed residual WRB signals at both the mRNA 
(Fig. 1b) and the protein level (Fig. 1c). This is unlikely to be due to incomplete recombination34 and may well be 
explained by the presence of contaminating fibroblasts or endothelial cells in the primary cell isolation. As the sta-
bility of the WRB protein in isolated adult cardiomyocytes is currently unknown we cannot fully exclude the pos-
sibility that some cells retained some WRB protein at the tested time point after knockout induction. Importantly, 
we observed that the steady-state levels of not only the CAML but also the TRC40 protein were strongly reduced 
upon cardiomyocyte-specific knockout of WRB.
The steady-state levels of some cardiomyocyte TA proteins are reduced. Next, we analyzed the 
steady-state levels of a subset of TA proteins by western blot and found that syntaxin 5 (Stx5), an essential SNARE 
involved in Golgi-to-ER trafficking, and emerin (EMD), a TA protein of the inner nuclear membrane37, were signif-
icantly less abundant compared to littermates not expressing the recombinase (Fig. 1e,f). In contrast, steady-state 
protein levels of Sec61β , an auxiliary translocon subunit, and syntaxin 6 (Stx6) were not significantly changed and 
those of syntaxin 8 (Stx8), an endosomal SNARE, not at all affected. Likewise, there was no effect on the steady-state 
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protein levels of a polytopic control membrane protein, STT3B, a subunit of the protein glycosyltransferase. 
Quantitative analysis of the transcripts of the tested TA proteins (Supplementary Fig. 1) excluded that the variations 

































































































































Figure 1. Knockout of WRB in cardiomyocytes results in reduction at steady-state level of TRC40 and 
CAML as well as Stx5 and emerin (EMD). (a) Schematic of the cardiomyocyte-specific tamoxifen inducible 
knockout of WRB. Administration of tamoxifen triggers nuclear import of MerCreMer recombinase expressed 
under the control of Myh6 promoter. This leads to recombination of the WRB locus in the WRBfl/fl mouse 
line. (b) mRNA levels of the main TRC40-pathway components relative to GAPDH in eight-week old Myh6-
MerCreMer negative and positive littermates two weeks after tamoxifen induction, measured by qPCR. Bars 
represent average + /− s.e.m. (n = 4, ***p-value < 0.001). (c) Cellular lysates from isolated cardiomyocytes 
were separated by SDS-PAGE and the main TRC40-pathway components were evaluated by western blot using 
GAPDH as loading control. An asterisk marks a cross-reactive protein. (d) Quantification of the blots as in (c). 
Bars represent average + /− s.e.m. (n = 7–16, ***p-value < 0.001). (e) Lysates from isolated cardiomyocytes were 
separated by SDS-PAGE and expression level of different TA proteins and of the multi spanning membrane 
protein (MSMP) STT3B was analysed by immunoblot using GAPDH as loading control. (f) Quantification of 
the blots as in e; bars represent average + /− s.e.m. (n = 6–15, ***p-value < 0.001).
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animals of the same age from a control mouse line carrying the MerCreMer recombinase gene and wild type 
WRB alleles did not show major alterations in the protein levels (Supplementary Fig. 2a–d), excluding side effects 
of tamoxifen injection, MerCreMer expression, or their combination as the cause of our observations.
CAML and TA protein levels are reduced in WRB ko hepatocytes. To generate a liver-specific WRB 
knockout, we crossed the same WRB floxed line, with a line expressing Cre recombinase under the control of the 
constitutively active albumin promoter38 (Fig. 2a). In our qPCR analysis, isolated hepatocytes showed a heteroge-
neous response to recombination. Reduction of WRB mRNA ranged from 5% to 90% (Fig. 2b), potentially due to 
the regeneration capacity of adult hepatocytes39 and clonal expansion of cells without the recombined transgene. 
Independently of the reduction level, all Cre-positive animals showed severe liver damage that was macroscopi-
cally visible upon dissection of the animals, and was corroborated by histological sections revealing fibrous areas 
and by elevated plasma levels of liver enzymes ALT and AST (Supplementary Fig. 4a,b). These strong general 
effects on the integrity of the liver support previous observations of the essential functions of TRC40 pathway in 
development and tissue homeostasis21–23,25,29,30. In contrast to enzymatic activities indicating liver damage, the 
serological levels of cholesterol and triglycerides in Cre-positive animals did not change significantly in compari-
son to control littermates (Supplementary Fig. 4c), indicating sufficient residual liver function.
As in cardiomyocytes, no major differences were observed in the mRNA levels of CAML and TRC40 in hepat-
ocytes (Fig. 2b). We observed that only the few animals that displayed a reduction in WRB mRNA of 70–90%, 
showed a significantly reduced protein level of both WRB and CAML, whereas TRC40 levels were not changed 
significantly (Fig. 2c,d). In addition, these animals confirmed the altered steady-state levels of a subset of TA pro-
teins including Stx5 and Stx6 (Fig. 2e,f) that was not caused by changes at the mRNA level (Supplementary Fig. 1), 
in accordance with the results obtained in cardiomyocytes (Fig. 1e,f). Animals with a weak reduction of WRB 
mRNA showed insignificant variations of WRB, CAML and TA protein levels (Supplementary Fig. 4d,e), which 
may suggest a threshold dependence of the knockout effects.
Sensitive TA proteins mislocalize in cardiomyocytes and hepatocytes. In order to investigate the 
subcellular localization of client TA proteins as a proxy for successful membrane targeting, we performed indirect 
immunostaining of isolated cardiomyocytes and hepatocytes. Not all TA proteins studied were severely affected 
by WRB knockout with respect to their localization. In cardiomyocytes we observed a strong reduction of Stx5 
and Stx6 in vesicular structures resembling the Golgi apparatus (Fig. 3a,b) as confirmed by co-staining with p115 
(Supplementary Fig. 3). In about 50% of the cells, emerin was less clearly localized to the striated cardiomyocyte 
ER and the nuclear envelope. No effect was observed for the well studied TRC40 substrate Sec61β 3,4 and Stx8 
(Fig. 3a,b). Evaluation of the localization patterns described above was conducted blindly by three independent 
investigators using a computational pipeline that shuffles and presents the images without revealing the genotype 
and an automated decoder that provides the scoring results. Generally, the effects on subcellular localization were 
correlated with the steady-state protein levels of the tested TA proteins (Fig. 1e,f). TA protein localization was 
unaltered in Cre-negative or -positive littermate cardiomyocytes from non-floxed animals injected with tamox-
ifen and analyzed at the same time point after injection (Supplementary Fig. 2e). In knockout hepatocytes, Stx5 
was also an example of a very strongly affected substrate as its Golgi localization was almost completely lost. For 
Stx8, a TA protein representing the other end of the spectrum based on the protein steady-state levels, we did 
not observe comparable alterations in targeting to membrane structures although the endomembrane system of 
Cre-positive hepatocytes appeared slightly perturbed in its overall morphology (Fig. 3c). We conclude that the 
effect of knocking out the TRC40 receptor leads to a spectrum of biogenesis defects in vivo depending on the TA 
protein client investigated. For some TA proteins such as the well-established TRC40 client Sec61β , the effects 
were mild whereas some but not all of the syntaxins investigated were severely affected. Indeed, our results high-
light Stx5 and Stx8 as examples of the respective extremes of TRC40 receptor dependence in vivo and implicate 
them as useful model proteins for the dissection of the protein features underlying differential TRC40-pathway 
dependence of TA protein clients.
A systematic yeast screen reveals only 2 strictly GET-dependent clients. In our analysis of endog-
enous TA proteins in differentiated mammalian cells, the TA proteins that were identified as strictly dependent on 
the TRC40 pathway were not dedicated to specific cellular functions (such as vesicle fusion) and did not belong 
to a certain protein family (such as the SNAREs). On the contrary, strong sensitivity of selected clients (e.g. Stx5 
or emerin) may depend on unique features specific to each TA protein. In order to extend our analysis to a greater 
number of TA proteins we turned to yeast, and performed a systematic screen of yeast TA proteins to determine 
which substrates are affected in cells lacking the GET pathway10.
From a recently generated SWAp-Tag yeast library40, we assembled a subset of yeast strains expressing 
N-terminally GFP-tagged TA proteins under the control of an intermediate strength, constitutive promoter 
(NOP1pr). The selection was conducted according to a list of predicted human TA proteins17, from which we 
extracted the 46 with known yeast homologues. We generated deletions of GET pathway genes in all 46 strains, 
either the double deletion get1/get2 (no GET receptor), single get3 deletion (no cytosolic targeting ATPase), or 
triple get1/get2/get3 deletion (no GET pathway) and analyzed them by fluorescence microscopy. This analysis 
revealed that only two out of the 46 TA proteins were severely affected by deletion of the GET pathway (Fig. 3d 
and Supplementary Fig. 5a–c). One of the two mislocalized TA proteins was the yeast homolog of Stx5, the 
well studied SNARE protein Sed510,36,41 and the other Lam5, a member of a recently characterized family of 
lipid transfer proteins42. Absolute expression levels, as quantified by flow cytometry measuring the fluorescence 
intensity of the tested GFP fusion proteins, revealed minor changes for Sed5, Sbh1 and Lam5 in GET mutants 
and absence of variation for Syn8 (Supplementary Fig. 5b). Western blot assessment of the steady-state levels of 
endogenous Sed5 implied that the mistargeted protein remained stable (Supplementary Fig. 5d,e), possibly due 
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to the action of various chaperones43. Importantly, Syn8, the yeast homolog of Stx8, was unaffected (Fig. 3d and 
Supplementary Fig. 5a,b) as were the 43 other TA proteins screened, including TA proteins that were previously 
shown to use the GET pathway in vitro such as Sec2210. Other yeast TA proteins are known to be mislocalized in 
cells lacking the GET receptor upon over-expression from a strong inducible promoter, such as Sbh1 (homolog 
of Sec61β ) and Ysy6 (homolog of mammalian Ramp4, also demonstrated to depend on TRC40 for targeting 
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Figure 2. A hepatocyte-specific knockout of WRB leads to a reduction of the TRC40 pathway 
membrane receptor and substrate TA proteins. (a) Schematic of the hepatocyte specific knockout of WRB. 
Cre recombinase is expressed under the control of albumin promoter in a WRBfl/fl mouse line, allowing 
recombination of the WRB locus (b) mRNA levels of WRB, CAML and TRC40 were analysed by qPCR. 
Boxplots depict the levels relative to GAPDH in six-week old Alb-Cre negative and positive littermates. Y-axes 
show 2−∆CP values. p-values are indicated. (c) Protein lysates from isolated hepatocytes were separated by SDS-
PAGE and expression level of the main pathway components were evaluated by western blot. Blots of knockout 
animals in the 25th percentile of the boxplot of WRB mRNA levels in b, and of control animals are shown. 
GAPDH was used as loading control. An asterisk marks a cross-reactive protein. (d) Quantification of the 
blots from (c). Bars represent average − /+ s.e.m. (n = 4, *p-value < 0.05; ***p-value < 0.001). (e) Lysates from 
isolated hepatocytes were separated by SDS-PAGE and expression level of known substrates of the pathway was 
evaluated by western blot. Blots of knockout animals in the 25th percentile of the boxplot of WRB mRNA levels 
in b, and of control animals are shown. GAPDH was used as loading control. (f) Quantifications of the blots 
from e. Bars represent average − /+ s.e.m. (n = 4, **p-value < 0.01; ***p-value < 0.001).
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situation and this may explain why they did not show significant variations in the screen. Importantly, the system-
atic yeast screen confirms a graded dependence of clients on the GET pathway with Stx5 (Sed5) and Stx8 (Syn8) 
representing the ends of the spectrum.
Stx5 is not stabilized by proteasomal inhibition. It has been proposed that strongly hydrophobic 
transmembrane domains strictly require TRC40-mediate targeting whereas more hydrophilic ones can be sub-
strates of alternative pathways44. Our results show that Stx5 is more dependent on the TRC40 pathway despite 
its transmembrane domain being less hydrophobic than that of Stx8 (47.6 and 61.3 respectively according to the 
Kyte-Doolittle scale45). We tested Stx5 and Stx8 in an in-vitro transcription/translation reaction coupled with 
insertion into canine pancreatic rough microsomes (RM). When the reaction was performed using rabbit reticu-
locyte lysate depleted of TRC40, membrane integration of both Stx5 and Stx8 was strongly inhibited (Fig. 4a–c). 
This result clearly shows that both proteins can be targeted by TRC40 in vitro and reveals that additional molecu-
lar mechanisms may govern TA protein biogenesis in vivo.
BAG6 is a component of the TA protein pre-targeting complex but is also known to be involved in the deg-
radation of mislocalized proteins via the ubiquitin-proteasome system6,7. Together with our finding that Stx5 
protein levels were lower in mammalian WRB knockout cells (Figs 1e,f and 2e,f) while those of Stx8 were nearly 
unchanged, this dual function of the BAG6-containing pre-targeting complex led us to test in HeLa cells whether 
Stx5 was targeted for proteasomal degradation in the absence of the TRC40 receptor. Cells were transfected with 



































































Figure 3. Depletion of the TRC40 pathway receptor results in mislocalization of a subset of TA-proteins 
in vivo. (a) Ventricular cardiomyocytes from eight-week old MerCreMer- (control) and MerCreMer+ (KO) 
Wrbfl/fl littermates two weeks after tamoxifen induction were isolated and subcellular localization of selected TA 
proteins (EMD, Stx5, Stx6, Stx8, Sec61β ) was analysed by indirect immunofluorescence. Images were acquired 
with a confocal microscope. The multi-spanning membrane protein LBR served as control. Scale bar: 20 µ m. 
(b) Quantification of mislocalization phenotype. For each protein, 22 to 98 cells isolated from 4 to 8 animals 
were examined. The scoring was performed blindly by three investigators using an image shuffling pipeline and 
automated genotype/phenotype decoder. The following criteria were applied to assign an “altered” phenotype: 
for Stx5, Stx6 and Stx8 loss of staining at membraneous structures resembling Golgi or endosomes; for Sec61β 
loss of staining at cellular striations resembling the sarcoplasmic reticulum; for emerin and LBR loss of staining 
at the nuclear rim and sarcoplasmic reticulum striations. (c) Isolated hepatocytes from six-week old animals 
were immunostained for either Stx5 or Stx8 and images were acquired with a confocal microscope. GM130 
was used as a Golgi marker. Scale bar: 20 µ m. (d) Live-cell microscopy of wild type and get1/get2 yeast cells 
expressing GFP-Sed5 or GFP-Syn8. Scale bar: 5 µ m.
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siRNA to specifically knock down WRB or TRC40 and were treated with the proteasomal inhibitor oprozomib 
(OPZ). No significant variations in steady-state levels were observed for Stx5 or Stx8 (Supplementary Fig. 6a,b) 
therefore suggesting that mistargeted Stx5 is not degraded by the proteasome.
The cytoplasmic domain of Stx5 is prone to aggregation and induces autophagy. Another cel-
lular process to degrade proteins or even entire organelles is autophagy46. We generated HEK293 cells allowing 
tetracycline-inducible overexpression of Stx5, Stx8, or chimeric proteins with swapped transmembrane domains 
and monitored autophagy induction via the relative levels of the lipidated form of LC3B, a known autophago-
somal marker47. Overexpression of Stx5 or a variant of Stx5 with the transmembrane domain (TMD) of Stx8 
(Stx5tmd8), but not full-length Stx8 or the inverse chimera, significantly increased the ratio of lipidated versus 
non-lipidated LC3B, indicating increased levels of autophagosomal membranes (Fig. 4d,e). This result strongly 
suggests that physicochemical properties of the cytoplasmic domain of Stx5 are responsible for the observed 
autophagy induction.
As autophagy is responsible for the clearance of protein aggregates, we wondered if the cytoplasmic domain of 
Stx5 has a higher tendency to misfold or aggregate compared to that of Stx8. We purified the cytoplasmic domains 
of Stx5 (333 amino acids) and Stx8 (216 amino acids) as MBP-tagged recombinant proteins and performed cir-
cular dichroism (CD) spectroscopy to monitor changes in secondary structures upon heating. We found that 
the cytoplasmic domain of Stx5 had a higher thermal instability and unfolding propensity relative to the same 
domain in Stx8 (Fig. 4f). An in-vitro aggregation assay confirmed these findings by showing that MBP-Stx5cyt 
incubated at 42 °C and 55 °C appeared in the insoluble pellet after centrifugation whereas MBP-Stx8cyt remained 
in the soluble fraction (Supplementary Fig. 6c).
We also detected a strong accumulation of TRC40 and a mild but significant stabilization of Stx5 in cells 
treated with chloroquine (CQ), a drug that inhibits lysosomal proteases by preventing acidification of lysosomes48. 
In contrast, variation in Stx8 steady-state levels was not significant (Supplementary Fig. 6d–g). These results indi-
cate that Stx5 is not only a substrate of lysosome-mediated degradation but can also induce autophagy through 
distinct properties of its cytoplasmic domain.
Figure 4. The cytoplasmic domain of Syntaxin 5 is aggregation-prone and can induce autophagy. (a) Stx5op and 
Stx8op were translated in vitro in a rabbit reticulocyte lysate or in a lysate immunodepleted of TRC40. (b) Integration 
into rough microsomal membranes (RM) was detected by glycosylation of the C-terminal opsin tag (opG) resulting 
in a slower-migrating protein detected by an opsin-specific antibody. (c) Quantification of glycosylation, percentage 
of total. Bars represent average + /− s.e.m. (n = 4, ***p-value < 0.001). (d) Stably transfected HEK Flp-In T-REx 
cells were cultured in absence or presence of tetracycline for 16 hours to induce expression of Stx5/Stx8 constructs. 
Cellular lysates were separated by SDS-PAGE and induction was verified by anti-GFP western blot. An increased ratio 
between the lipidated (LC3B-II) compared to non-lipidated (LC3B-I) LC3B was evaluated by blot and quantified 
in e Bars represent average + /− s.e.m. (n = 4, *p-value < 0.05; ***p-value < 0.001). (f) Far-UV circular dichroism 
measured at 220 nm and increasing temperatures for MBP-Stx5cyt (black trace) and MBP-Stx8cyt (gray trace).
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FAM134B is involved in Stx5 degradation. In order to confirm an active role for autophagy in the clear-
ance of Stx5, we used siRNA to selectively down regulate in HeLa cells two autophagy cargo receptors: FAM134B 
and p62/SQSTM1. FAM134B was recently identified as a member of the reticulon protein family involved in 
turnover and degradation of the ER and membrane-associated proteins by autophagy49. p62/SQSTM1 is a known 
cargo receptor that mediates autophagosomal degradation of ubiquitinated and non-ubiquitinated cytosolic 
aggregates50.
We observed a significant stabilization of Stx5 in cells silenced for TRC40 in combination with FAM134B 
(Fig. 5a,b). Stx8 was not affected by down-regulation of FAM134B (Fig. 5a–c). p62/SQSTM1 silencing stabilized 
neither Stx5 nor Stx8 (Fig. 5d–f). These results suggest the existence of a mechanism of Stx5 degradation after its 
membrane integration in a FAM134 dependent manner.
Discussion
The GET/TRC40 pathway was discovered by a combination of experimental strategies using in-vitro biochemical 
dissection in mammalian lysates, structural biology, and the model organism S. cerevisiae3,4,10,18. These studies 
identified the key components of the pathway in the cytosol and at the ER membrane. They were also instru-
mental in demonstrating the interaction of Get3/TRC40 with client TA proteins, with the pre-targeting complex 
and its ER receptor. These approaches have culminated in a detailed mechanistic model of the targeting process. 
However, only a small selection of client TA proteins was studied based on practical aspects such as efficient trans-
















































































































































































Figure 5. Stx5 is degraded by a FAM134B-dependent autophagy mechanism. (a) Control-silenced HeLa 
cells or knockdown cells for WRB or TRC40 were co-transfected with a control siRNA or with a FAM134B-
specific siRNA. Cellular lysates were analyzed by Western blot for the indicated proteins. Graphs in (b,c) show 
quantification of the expression levels of Stx5 and Stx8 respectively. Bars represent average + /− s.e.m. (n = 6, 
**p-value < 0.01). (d) Control-silenced HeLa cells or knockdown cells for WRB or TRC40 were co-transfected 
with a control siRNA or with a p62-specific siRNA. Cellular lysates were analyzed by Western blot for the 
indicated proteins. Graphs in e,f show quantification of the steady-state levels of Stx5 and Stx8 respectively. Bars 
represent average + /− s.e.m. (n = 4, variations not significant).
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actual client spectrum that depends on the pathway in vivo is unknown and so are the properties of clients that 
make them GET/TRC40 pathway dependent in their targeting.
In higher eukaryotes, TRC40 and the subunits of its receptor WRB and CAML have been investigated based 
on screens that identified them as being involved in sensory processes25,26,31,32. These physiological studies dissect 
the in-vivo function of the GET/TRC40 pathway proteins from the behavioral phenotype to cellular morphol-
ogy and detect an impairment of the synaptic endomembrane system that is required for sensory transduction. 
Interestingly, it was demonstrated that the most critical substrate of WRB-dependent targeting in hair cells of the 
inner ear is otoferlin. In zebrafish and in mouse, hair-cell specific knockout of WRB lead to hearing deficits that 
phenocopy loss of otoferlin and can be rescued by overexpression of this TA protein in zebrafish26.
We investigated tissue-specific WRB knockout mice to analyze the steady-state levels and subcellular localization 
of a set of TA proteins including well-established model TA proteins such as Sec61β and different SNAREs in two bio-
chemically amenable differentiated cell types, cardiomyocytes and hepatocytes. We find a graded response of different 
TA protein clients to loss of the TRC40 receptor with some being much more destabilized and mislocalized than 
others. In-vitro studies44,51 have suggested alternative targeting mechanisms involving cytosolic chaperones such as 
Hsc70/Hsp40 or SRP and additional SRP-independent targeting pathways for TA proteins may exist19,52. Nevertheless, 
the properties of a substrate that determine its strict dependence on a specific pathway are still unknown.
Together with a recent study showing that Stx5 and Stx6 are critically affected TA proteins in pancreatic beta 
cells lacking TRC4023, our results identify Stx5 as one of the substrates that strictly depends on the TRC40 path-
way for its biogenesis. This dependence is conserved in the yeast system and therefore reflects a property of the 
client protein. We exploited the fact that another SNARE, Stx8, was not affected by loss of WRB in a chimeric 
approach and found that the cytoplasmic domain of Stx5 stimulated autophagy in cells overexpressing constructs 
that included this part of the TA protein irrespective of the transmembrane domain on which it was presented. It 
has been hypothesized that very hydrophobic transmembrane domains require TRC40 whereas more hydrophilic 
ones can be substrates of alternative pathways44 or capable of spontaneous insertion53. Our findings suggest that 
although properties of the transmembrane domain of TA proteins might be relevant to drive targeting and to 
ensure the fidelity of membrane integration, the cytoplasmic domain may be even more important for the fate of 
the protein during biogenesis in vivo.
Accumulation of protein aggregates is a metabolic vulnerability for cells that have to ensure rapid clearance 
of these aggregates. When membrane targeting via the TRC40 pathway is impaired, due to loss of WRB, the flow 
of aggregated or misfolded Stx5 and hence its turnover by autophagy increases. Our results indicate a role of 
FAM134B in Stx5 clearance. This protein was recently shown to have an essential function in the turnover of ER 
by autophagy49. Mice lacking FAM134B display an increased ER volume and structure but also a fragmented and 
elongated Golgi apparatus49.
As silencing of FAM134B stabilizes Stx5 on protein level (Fig. 5a,b) it is conceivable that a certain proportion 
of Stx5 is inserted into membrane by alternative targeting mechanisms even in absence of a functional TRC40 
pathway. Nevertheless, the observation that Stx5 is extremely reduced in absence of WRB or TRC40 raises the 
possibility that Stx5 targeted to membrane via alternative pathway may be not fully functional. The presence of a 
non-functional SNARE protein may lead to its active removal and degradation by autophagy. This could be due 
to many reasons. In the absence of the TRC40 pathway, the targeting fidelity of alternative targeting mechanisms 
may not support targeting to the right ER domain. It is also conceivable that the TRC40 pathway might mediate 
the biogenesis of a factor that is essential for the stability and function of Stx5. Another possibility is that Stx5 is 
so exquisitely sensitive to loss of the TRC40/GET pathway because it requires the chaperone holdase activity of 
TRC40/Get320,43 in addition to the TA protein targeting function.
In general, our results indicate that the biogenesis of the vast majority of TA proteins is not acutely affected 
by deletion of the TRC40/GET pathway in vivo. Indeed, decreasing the number of available receptor sites in 
vitro18 or overexpressing a dominant negative mutant of TRC40 in transfected mammalian cells54 slows down 
membrane integration and increases the amount of stalled TA proteins in the cytosol. Cells may then cope with 
accumulating TA proteins by promoting their membrane integration via alternative pathways or by ensuring 
the degradation of clients prone to aggregate or to cause proteotoxic stress (i.e. Stx5). Therefore, it may not be 
appropriate to reduce the model of TA protein biogenesis to a mere sequence of recognition-targeting-integration 
events. Instead, it may be necessary to consider the process in the context of the cellular proteostatic network that 
includes additional mechanisms of quality control and degradation. In this view, the extent to which a TA pro-
tein is impaired in its biogenesis by loss of the TRC40/GET pathway will depend on the properties of the whole 
protein, cytoplasmic domain and transmembrane segment, as well as its abundance in a given cell type. Further 
tissue specificity will arise from the nature of the pertinent cellular proteostasis network (components and their 
abundance). The phenotypes observed upon TRC40 pathway knockout in the diverse cell types of multicellular 
organisms will reflect the most vulnerable and important TA proteins in that cell – as illustrated by the conse-
quences of impairing Stx5/6 biogenesis in pancreatic beta cells for insulin secretion23 or by the defects in otoferlin 
targeting observed in the WRB inner hair cell knockout26. These results expand and refine our knowledge on the 
TRC40 pathway in eukaryotes and provide a first view on its integration into tissue physiology.
Methods
Cell lines. HeLa P4 cells were grown in DMEM (Gibco) supplemented with 10% (v/v) FBS (Gibco). 
Plasmid and siRNA transfections were performed with BBS-calcium phosphate55. For siRNA-medi-
ated knockdowns, cells were transfected twice at 48 hours interval, using RNA oligos specific for WRB 
(sense AAAUCCAACAGGUAAUUCCAACACC, antisense GGUGUUGGAAUUACCUGUUGGAUUU, 
Invitrogen), TRC40 (s1675, Ambion), FAM134B (sense AGGUAUCCUGGACUGAUAAUG, antisense 
CAUUAUCAGUCCAGGAUACCU, Sigma Aldrich), p62/SQSTM1 (sense GCAUUGAAGUUGAUAUCGAU, 
antisense AUCGAUAUCAACUUCAAUGC, Sigma Aldrich), and non targeting control siRNA (AM4635, Ambion).
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Hek Flp-In T-REx were cotransfected with combinations of the recombinase containing vector pOG44 and 
the pCDNA5-FRT-TO-N-GFP constructs described in the “Plasmids” section. Recombined clones were selected 
for resistance to Hygromycin B (150 µ g/ml). Expression of Stx5, Stx8 or chimeric proteins was induced by adding 
1 µ g/ml tetracycline to cell medium for 16 hours.
Mice. All the procedures involving animals were reviewed and approved by the Institutional Animal Care 
and Use Committee of the University Medical Center Göttingen, in compliance with the humane care and use of 
laboratory animals.
WRBfl/fl line was previously described26. Myh6-MerCreMer (B6.FVB(129)-Tg(Myh6-cre/Esr1*)1JmK/J) and 
Albumin-Cre mice (B6.Cg-Tg(Alb-cre)21Mgn/J) were purchased from the Jackson Laboratory.
MerCreMer dependent recombination was induced in six-week old animals by injection of 40 mg/kg of 
tamoxifen (diluted in EtOH-soybean oil) as previously described34.
Genotyping. Mice tails were harvested before three weeks of age, and lysed for 14–16 hours at 56 °C in 
DirectPCR-Tail Lysis reagent (Peqlab), plus proteinaseK (20 µ g/mL), followed by inactivation at 85 °C, 45 min. 
Supernatant was used as PCR template, with MangoTag (Bioline) and primers for wt and transgene as shown in 
“Primers” Table. Products were then analysed with standard agarose gel electrophoresis.
Primary cells isolation and culture. At 8 weeks of age and two weeks after tamoxifen induction of the 
MerCreMer recombinase, ventricular cardiac myocytes were isolated by retrograde perfusion with a modified 
Langendorff 35 setup with minor changes. Briefly, hearts were perfused at a rate of 4 ml/min with Ca2+ free oxy-
genated perfusion buffer for 4 min, 37 °C, followed by perfusion with collagenase type II (600 U/ml in perfusion 
buffer supplemented with 12.5 µ M CaCl2, Worthington Biochemical Corporation) for 8 min at 37 °C. Digested 
ventricles were minced in collagenase-containing buffer and the cardiomyocytes were released by gentle pipet-
ting. Digestion was stopped with 10% bovine calf serum in perfusion buffer, and the cells were washed twice in 
the same buffer. The quality of the preparations was verified in a Neubauer chamber, and isolations with less than 
60% rod shape cells were discarded. For indirect immunofluorescence microscopy, isolated cardiomyocytes were 
plated on laminin (BD Biosciences)-coated glass coverslips.
Primary hepatocytes were isolated from six-week old animals by perfusing livers with collagenase and subject-
ing the isolated cells to a Percoll gradient. Briefly, the liver was perfused via the Vena cava caudalis, using the Vena 
portae as outflow with 125 mL Krebs-Ringer/EGTA, followed by perfusion with Krebs-Ringer substituted with 
Collagenase/HEPES/CaCl2 for 4 min. After perfusion, the liver was excised, rinsed in Williams E (Gibco) and 
pulled apart with forceps to wash out the cells, followed by a filtering step (70 µ m pore size). The cells were then 
subjected to a Percoll gradient (GE Healthcare). Hepatocytes were washed once and resuspended in Williams E 
(1 g of cells in 50 mL). The amount of cells was quantified using a counting chamber. For indirect immunofluores-
cence, cells were plated on collagen-coated glass coverslips.
Blood withdrawal. Animals were anesthetized with isoflurane followed by injection of approx. 400 µ L 
Nembutal (10 mg/mL). Blood was taken from the Vena cava caudalis with a small syringe after opening the body 
cavity. For obtaining serum for the analysis, the syringe was rinsed with lithium-heparine (Sigma-Aldrich) before 
drawing blood. Samples were then centrifuged at 500 g for 30 min to collect the serum. Blood analysis was carried 
out by the Department of Clinical Chemistry of the University Medical School Göttingen.
Histology. Livers were embedded in Paraffin and 3 µ m sections were obtained at a microtome. Sections were 
stained with hematoxylin-eosin or Goldner staining kit (Engelbrecht).
qPCR. mRNA was isolated from samples using a Roche High Pure RNA isolation kit, following manufacturer’s 
instructions. Equal amounts of total RNA were subjected to cDNA synthesis (SuperScript III First-Strand 
Synthesis System). qPCRs were performed using a Roche SYBR green Master Mix in a Roche Lightcycler480. 
mRNA levels were normalized to GAPDH mRNA.
Protein extraction and Western Blot. For mammalian samples, equal amounts of cells were lysed in sol-
ubilization buffer (50 mM Tris-HCl pH7.4, 10 mM NaCl, 5 mM EDTA, 2.5 mM EGTA, 1.5% Triton X-100, 0.75% 
Na-deoxycholate, 0.1% SDS) supplemented with protease inhibitors. Proteins were precipitated by TCA before 
SDS-PAGE separation and immunoblot analysis.
For yeast protein extraction, cells were recovered by low speed centrifugation and resuspended in 100 mM 
NaOH for 10 minutes. Cells were pelleted and lysed in SDS loading buffer.
Primary and secondary antibodies were diluted (as described in the “Antibodies” Table) in blocking buffer 
(5% milk in PBS, 0.1% Tween). Blots were imaged using an Odyssey Sa Infrared imaging system with IRDye 
LiCOR secondary antibodies. Quantification was performed using the ImageStudio Software (LI-COR).
Indirect immunofluorescence microscopy. For immunofluorescence, cells were fixed as described in the 
“Antibodies” Table. Samples were blocked with 10% FCS in PBS for 30 min and incubated with primary antibod-
ies diluted in blocking buffer at 4 °C overnight. Incubation with Alexa Fluor secondary antibodies (Thermo Fisher 
Scientific) was performed for 1 hour at room temperature, and the samples were mounted with Mowiol-DAPI.
Images were taken using a LSM 510-META confocal laser scanning microscope (Zeiss) with a 63x 
Plan-Neofluar 1.3 NA water-corrected objective and appropriate filter settings. Images were processed using 
ImageJ software (https://imagej.nih.gov/ij/).
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Blind annotation KNIME workflow. Using a KNIME workflow, images were copied and given a random 
name after which they were manually annotated. The results of the annotation were decoded using the same 
workflow. The workflow was written in KNIME 3.2.1 (https://www.knime.org) and requires the KNIME File 
Handling Nodes (3.2.2.v201609201941) plugin.
Yeast strains. Yeast strains were selected from the SWAp-Tag library40. SGA crosses were carried out as 
described previously56 by crossing the strains with a query strain (MATα his3∆ 1 leu2∆ 0 met15∆ 0 ura3∆ 0 can1∆ 
::STE2pr-spHIS5 lyp1∆ ::STE3pr-LEU2) carrying combinations of get1∆::KAN, get2∆::NAT, and get3∆::BLE to 
yield get1/get2, get3, and get1/get2/get3 strains, as indicated. The query strains with and without GET1/GET2/GET3 
replacements were also used for Western blots, as indicated.
Live-cell imaging. Logarithmic phase cultures of indicated yeast strains grown in synthetic dropout 
media were diluted and transferred into BioConext (United Chemical Technologies) and Concanavalin A 
(Sigma-Aldrich) coated 384-well glass-bottom plates (Matriplate, Brooks Life Science Systems). Microtiter plates 
were automatically imaged at 30 °C on an Imaging Machine 03-dual (Acquifer) widefield high content screen-
ing microscope, equipped with a white LED array for bright field imaging, an LED fluorescence excitation light 
source, an sCMOS (2048 × 2048 pixel) camera, a temperature-controlled incubation chamber, and a stationary 
plate holder in combination with movable optics. Images were acquired with 470 nm filter cubes (Ex 469/35, 
Em 525/39, dichroic 497) using 3 z-slices (dz = 1 µ m) and a 40x CFI Super Plan Fluor ELWD N.A. 0.60 (Nikon), 
using 500 ms integration time. The focal plane was detected in the bright field channel using a yeast autofocus 
algorithm.
Flow cytometry. Yeast strains were cultured in synthetic complete media at 30 °C overnight, diluted to 
OD600 0.2, cultured for 4 hours at 30 °C, washed and resuspended in PBS. Fluorescence intensity was measured 
with a BD FACSCanto flow cytometer (BD biosciences). Data were analyzed with custom R scripts using the 
Bioconductor package FlowCore57. GFP fluorescence intensities were represented as Kernel density plots using 
the ggplot2 graphing package58.
In vitro transcription/translation. Stx5op and Stx8op were synthesized using a TnT Quick Coupled 
Transcription/Translation System (Promega) according to manufacturer instructions. Briefly, 200 ng of plas-
mid containing the coding sequence of the protein of interest were incubated with 10 µ l of reaction mix-
ture. After 45 minutes, rough microsomes were added and the reaction was incubated for 45 more minutes. 
Immunodepletion of TRC40 was performed as previously described59.
Protein purification. pQE80-MBPtevStx5cyt and pQE80-MBPtevStx8cyt were transformed into E. coli 
BL21AI. Induction of recombinant proteins was performed at 30 °C by addition of 0.5 mM IPTG for 2 hours. Cells 
were lysed in PBS with an Avestin-Emulsiflex and lysates cleared by centrifugation at 100,000 g for 45 minutes. 
The lysates were incubated with an amylose resin (NEB) for one hour at 4 °C. The resin was washed three times 
with ten volumes of PBS and finally the proteins eluted in PBS supplemented with 20 mM maltose.
Aggregation assay and circular dichroism spectrocopy. 10 µ M of MBPtevStx5cyt or MBPtevStx8cyt 
were incubated at different temperatures (as shown in Supplementary Fig. 6c) for one hour. Insoluble material 
was separated by centrifugation at 25,000 g for 20 minutes. Fractions of soluble and insoluble proteins were ana-
lysed by SDS-PAGE and stained by coomassie blue.
Changes in the secondary structure of the cytosolic domains of Stx5 and Stx8 were determined by record-
ing far-UV CD spectra at 2 °C temperature intervals (from 20 °C to 62 °C) using a Chirascan qCD (Applied 
Photophysics). For these measurements, proteins were dialyzed against CD buffer (30 mM Na-phosphate pH 7, 
300 mM NaF, 0.1 mM TCEP) and diluted to 10 µ M.
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For pGem3Z-Stx5op, the coding sequence of Stx5 was amplified from heart 
cDNA using primers #1 and #2. The KpnI/HindIII fragment was then cloned 
into pGEM3Z (Promega). pGem3Z-Stx8op was obtained similarly using 
primers #3 and #4 
For pQE80-MBP-Stx5cyt, a KpnI/XhoI fragment was obtained using pGem3Z-
Stx5op as template and primers #1 and #5. The fragment was cloned into 
pQE80-MBPtev1. pQE80-MBP-Stx8cyt was obtained similarly using pGem3Z-
Stx8op as template and primers #3 and #6. 
pCDNA5-FRT-TO-GFPStx5 was obtained by amplification of pGem3Z-Stx5op 
template with primers #1 and #11. The KpnI/XhoI digested fragment was 
cloned into pCDNA5-FRT-TO-N-GFP (Invitrogen). pCDNA5-FRT-TO-
GFPStx8 was obtained similarly using pGem3Z-Stx8op as template and 
primers #2 and #11. 
The chimeric Stx5-Stx8 constructs were obtained by fusion PCR. 
For pCDNA5-FRT-TO-GFPStx5tmd8 the coding sequence of the cytosolic 
domain of Stx5 was amplified from pGem3Z-Stx5op using primers #1 and #7 
whereas the region encoding the transmembrane segment of Stx8 was 
amplified from pGem3Z-Stx8op using primers #8 and #11. The PCR products 
were mixed in equimolar ratio and used as template for the fusion PCR using 
primers #1 and #11. A KpnI/XhoI fragment obtained from this final PCR was 
cloned into pCDNA5-FRT-TO-N-GFP. 
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For pCDNA5-FRT-TO-GFPStx8tmd5 the coding sequence of the cytosolic 
domain of Stx8 was amplified from pGem3Z-Stx8op using primers #3 and #9 
whereas the region encoding the transmembrane segment of Stx8 was 
amplified from pGem3Z-Stx5op using primers #10 and #11. The PCR 
products were mixed in equimolar ratio and used as template for the fusion 
PCR using primers #1 and #11. A KpnI/XhoI fragment obtained from this final 
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Supplementary Table 1: Primers 
# Name Sequence (5'-3') Application 








5 Stx5-Nterm-XhoI-R ATACTACTCGAGTCACCGATTGGAGGTAAC cloning 
6 Stx8-Nterm-XhoI-R ATACTACTCGAGTCACCCACAGGAAGCTGA cloning 
7 Stx5-Stx8-R GCAATAAGATCACCATTATCATCCGATTGGAGGTAACTGACTGG cloning 
8 Stx5-Stx8-F CCAGTCAGTTACCTCCAATCGGATGATAATGGTGATCTTATTGC cloning 
9 Stx8-Stx5-R GGAAGATTTTGACCATGAGCCACCCACAGGAAGCTGACTTTCTG cloning 
10 Stx8-Stx5-F CAGAAAGTCAGCTTCCTGTGGGTGGCTCATGGTCAAAATCTTCC cloning 
11 opsinSTOP-XhoI-R TATACACTCGAGTCAGCCCGTCTTGTTGGAGAAAGG cloning 
12 mWRB-Ex1-F AGCTTCGTGTTCGGGTGTAAC qPCR 
13 mWRB-Ex2-R TTGACGGTGGACAGCTCCTG qPCR 
14 mWRB-Ex3/4-F CTACATACTACAAGCAGCGCTGATG qPCR 
15 mWRB-Ex5-R ATCCAACAGGTGATTCCAATTCCAC qPCR 
16 mTRC40-F GTCCTTGTACGAGACGGAGC qPCR 
17 mTRC40-R TTGCAGGGTTTCTCAGGGTC qPCR 
18 mCAML-F CTCACCACGGCCTAGAACAG qPCR 
19 mCAML-R AACTCTTCCGCGGTACTTCC qPCR 
20 mGAPDH-F CCAATGTGTCCGTCGTGGATCT qPCR 
21 mGAPDH-R GTTGAAGTCGCAGGAGACAACC qPCR 
22 mStx5-F GCGGAAACGCTACGGATCTA qPCR 
23 mStx5-R GAGTGCTGTCACTGCTGCTA qPCR 
24 mStx6-F TCTCACGAGTTGGAGAGCAC qPCR 
25 mStx6-R AGAGGATGGCTATGGCACAC qPCR 
26 mStx8-F GGAGGGGGATCGAAGACAGA qPCR 
27 mStx8-R GCTTCTTCGCTCATCAGGCT qPCR 
28 mEMD-F GACCACCAAGACATACGGGG qPCR 
29 mEMD-R AGTGTGCGATGCTCTGGTAG qPCR 
30 mSec61β-F ATGTGGCGATTCTACACGGAA qPCR 
31 mSec61β-R GCAGCATAAATACAGCAGCGA qPCR 
32 mSTT3B-F CTCCAGTCCAAGTGTGGTCC qPCR 
33 mSTT3B-R TGATAGCCGTAGTCCCACCA qPCR 
34 wt-Forward TTGGTGAGGCTTGTCTCTGGCGATTT Genotyping 
35 wt-Reverse GTTGATCTTCCTTTCCAGCCTGGCGTAT Genotyping 
36 dneo-Forward AGTGTACACGCGTACTAGTCTAGCGAA Genotyping 
37 dneo-Reverse ACTCAAAGGCAACAGCCAAGATAAGCA Genotyping 
38 oIMR3798 AGGTGGACCTGATCATGGAG Genotyping 
39 oIMR7338 CTAGGCCACAGAATTGAAAGATCT Genotyping 
40 oIMR7339 GTAGGTGGAAATTCTAGCATCATCC Genotyping 
41 oIMR8346 ATACCGGAGATCATGCAAGC Genotyping 
42 cre-only-F ACTGACCGTACACCAAAATTTGC Genotyping 
43 cre-only-R CCGCATAACCAGTGAAACAGC Genotyping 
44 Alb-pr2-F GTATATTAGAGCGAGTCTTTC Genotyping 
45 cre2_R ACCTCATCACTCGTTGCATC Genotyping 
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Supplementary Table 2: Antibodies 
Antigen Species Source Cat. No. Lot No. Dil. (WB) 
Immunofluorescence dilution, Fixation 
Cardiomyocytes Hepatocytes HeLa 
Na+/K+ ATPase 




SC-21712 G3004 1:1000       
GAPDH Mouse Biotrend Chemikalien  5G4 
13/06-
G4-C5 
1:120000       





Synaptic systems  359 004   1:500       
TRC40 (Asna1) Rabbit Proteintech 15450-1-AP   1:1000       
Stx5 Rabbit Synaptic systems  110053 
110053/
13 





Stx6 Rabbit Synaptic systems  110062   1:1000 1:200, PFA     
Stx8 Rabbit Synaptic systems  110083 
110083/
9 












    1:500 1:300, MeOH     


























5021240 1:1000       




sc-9996  F0713  1:1000       
FAM134B Rabbit Ivan Dikic, Frankfurt   1:1000    
p62/SQSTM1 Mouse abcam ab56416 
GR2826
02-1 
1:5000    
Sed5 Rabbit 
Hans Dieter Schmidt, 
Göttingen     1:5000       
Vma2 Mouse Molecular probes A-6427   1:1000       
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Supplementary Figure Legends 
 
Supplementary Figure 1 Quantitative analysis of TA protein mRNAs. mRNA 
levels of investigated TRC40-pathway substrates relative to GAPDH 
cardiomyocytes and hepatocytes were determined by qPCR. Bars represent 
average +/- s.e.m. Variations are not significant by the student’s t test. 
 
Supplementary Figure 2 Control experiments addressing putative effects of 
tamoxifen-induced MerCreMer translocation to the nucleus in a WRB non-
floxed (Wrbwt/wt) Cre+ control mouse line. (a) TRC40-pathway components of 
ventricular cardiomyocytes isolated from 8-week old MerCreMer-positive, 
tamoxifen-induced control animals were analyzed by Western blot using 
GAPDH as loading control. An asterisk marks a cross-reactive protein. (b) 
Quantification of blots as in a. Bars represent average +/- s.e.m. (n=5, *p-
value<0.05). (c) TA proteins of ventricular cardiomyocytes isolated from the 
MerCreMer-positive control animals were analysed by western blot using 
GAPDH as loading control. (d) Quantification of blots as in c; bars represent 
average +/- s.e.m. (n=5). (e) Cardiomyocytes were subjected to indirect 
immunofluorescence staining of TA proteins and confocal images were 
acquired. LBR, a multi-spanning membrane protein, served as a negative 
control. Scale bar: 20 µm. 
 
Supplementary Figure 3 Colocalization of SNARE proteins with a Golgi 
marker. Cardiomyocytes isolated from WRBfl/fl, Cre- and WRBfl/fl, Cre+ 
littermates were subjected to indirect immunofluorescence for Stx5, Stx6 and 
Stx8 in combination with the Golgi marker protein p115. Images were 
acquired using a confocal microscope. Scale bar: 20 µm. 
 
Supplementary Figure 4 Characterization of the consequences of WRB 
knockout in the liver. (a) Paraffin sections of liver were subjected to Goldner 
or HE staining. Representative images of a WRBfl/fl, Cre- and a WRBfl/fl, Cre+ 
8-week old animal are shown. Original magnifications: images with Goldner 
staining 400x, images with HE staining 200x. Goldner staining was used to 
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reveal connective tissue. Nuclei appear in dark purple, cytosol in pink, and 
collagen in light blue. Hematoxylin and Eosin (HE) staining was used to 
assess general morphology. Nuclei are stained in dark purple, cytosol is 
stained in pink, and erythrocytes appear red. (b) Blood values of the liver 
enzymes Aspartate Transaminase (AST) and Alanine Transaminase (ALT) 
were measured in WRBfl/fl Cre- and Cre+ six-week old littermates. Graphs 
show average -/+ s.e.m. (n=9 (Cre-), n=7 (Cre+) ***p-value<0.001). (c) 
Cholesterol and triglyceride concentration in plasma of WRBfl/fl Cre- and Cre+ 
six-week old littermates. Graphs show average -/+ s.e.m. (n=4, the variations 
are not significant by student’s t test). (d) Western blots assessing the 
correlation between residual WRB mRNA levels and the steady-state protein 
levels of different TRC40 pathway components in hepatocytes isolated from 
six-week old animals. Blots of Cre+ littermates of the 25th (++) and 50th (+) 
percentile of the boxplot in Fig. 2b, together with two Cre- animals are shown. 
Protein amounts were quantified relative to GAPDH and shown as a bar 
diagram for each individual blot. An asterisk marks a cross-reactive protein. 
(e) Western blots assessing the correlation between residual WRB mRNA 
levels and the steady-state protein levels of the TA proteins Stx5 and Stx8 in 
hepatocytes isolated from six-week old animals. The same samples as in c 
were used and analysis was performed as described for c. 
 
Supplementary Figure 5 Steady-state protein levels and localization of TA 
proteins in get mutants lacking either the GET receptor, Get3, or both. (a) 
Live-cell microscopy images showing localization of selected genomically N-
terminally GFP-tagged TA proteins in S. cerevisiae get1/get2, get3, and 
get1/get2/get3 mutant strains. (b) Yeast strains depicted in panel (a) were 
analyzed by flow cytometry and fluorescence intensity distribution in wild type 
and get mutant strains are shown. BY4741 strain (gray trace) not expressing 
GFP was used as a negative control. (c) List of S. cerevisiae homologs of 
predicted human TA proteins indicating the localization of their genomically N-
terminally GFP-tagged versions in wt and get1/get2, get3, and get1/get2/get3 
yeast strains based on live-cell microscopy. (d) Protein levels of native Sed5 
were tested by western blot in wt, get1/get2, get3, and get1/get2/get3 yeast 
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strains. The protein Vma2 was used as a loading control. (e) Quantification of 
blots from c. Bars represent average -/+ s.e.m. (n=3, **p-value<0.01). 
 
Supplementary Figure 6 Comparison of Stx5 and Stx8 reveals different 
requirements for their cellular degradation. (a) Control siRNA treated HeLa 
cells or siRNA-mediated knockdown cells for WRB or TRC40 were incubated 
for 4 hours with 10 µM oprozomib (OPZ), an inhibitor of the proteasome, or 
DMSO as control. Cellular lysates were analyzed by Western blot for the 
indicated proteins. Graph in (b) shows quantification of the steady-state levels 
of Stx5 and Stx8 relative to the Na/K-ATPase. Bars represent average +/- 
s.e.m. (n=3) (c) Recombinant MBP-Stx5cyt and MBP-Stx8cyt were incubated 
at the indicated temperature. Soluble and insoluble proteins were separated 
by centrifugation. Fractions were loaded onto an SDS-PAGE gel and 
visualized by Coomassie staining. (d) Control silenced HeLa cells or 
knockdown cells for WRB or TRC40 were treated for 6 hours in the presence 
or absence of 100 µM chloroquine (CQ). Cellular lysates were analyzed by 
western blot for the indicated proteins. Graphs in (e-g) show quantification of 
the steady-state levels of TRC40, Stx5, and Stx8. Bars represent average +/- 
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Gene Localization inSWAT library
Change in localization in get1/get2,
get3, get1/get2/get3 strains
LAM5 punctate, ER partial loss of puncta and ER staining
FMP32 faint mitochondria
SED5 punctate partial loss of puncta
BET1 punctate no visible change
BOS1 punctate no visible change
CYB5 ER no visible change
FIS1 mitochondria no visible change
GEM1 mitochondria no visible change
GOS1 punctate no visible change
HFD1 ER no visible change
LAM6 punctate no visible change
NYV1 vacuole no visible change
PEP12 punctate no visible change
SBH1 ER no visible change
SCS2 ER no visible change
SCS22 cytosol no visible change
SEC20 ER no visible change
SEC22 ER no visible change
SFT1 cytosol no visible change
SNC1 punctate, cytosol no visible change
SNC2 punctate no visible change
SSO1 vacuole no visible change
SSO2 cell periphery no visible change
SSS1 ER no visible change
SYN8 punctate no visible change
TLG1 punctate no visible change
TLG2 punctate no visible change
TOM7 mitochondria no visible change
UBC6 ER no visible change
USE1 ER no visible change
VAM3 vacuole no visible change
VPS64 ER no visible change
VTI1 punctate no visible change
YDL012C bud tip, bud neck no visible change
YDR034W-B cell periphery no visible change
YLR283W ER no visible change
YSY6 ER no visible change
FAR10 faint no visible change
UFE1 faint no visible change
YSP2 faint no visible change
COX16 not in library not in library
HMX1 not in library not in library
LAM4 not in library not in library
SBH2 not in library not in library
YDR210W not in library not in library
αSed5
αVma2
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In order to investigate the role of the TRC40 pathway in heart physiology 
and disease development, a cardiomyocyte-specific, tamoxifen inducible 
knockout of WRB was generated by crossing two mouse lines: (i) a 
MerCreMer recombinase line under the control of the cardiac Myh6 
promoter (from Jackson Laboratory) and (ii) a previously described wrbfl/fl 
line, where exons 2 to 4 in the wrb locus are flanked by LoxP 
recombination sites (Vogl et al., 2016). In parallel, a second mouse line 
was generated in order to control for putative unspecific effects due the 
MerCreMer recombinase rather than the depletion of WRB (manuscript 2). 
 
I focused particularly on heart muscle due to the association of WRB with 
congenital heart disease in Down syndrome patients (Egeo et al., 1998) as 
well as the severe cardiac abnormalities observed in the constitutive WRB 
knockdown models in medaka fish (Murata et al., 2009) and Xenopus 
laevis (Sojka et al., 2014) embryos. 
 
Although several molecular aspects of the TRC40 pathway have been 
described by in vitro approaches over the years, it is not known how the 
different TRC40 pathway components respond in vivo once the receptor 
function is impaired. In order to gain insights into this, the components 
TRC40 and CAML were evaluated by Western blot in cardiomyocytes from 
the WRB knockout and cre recombinase control lines. The analysis 
confirmed an efficient knockout of WRB in heart upon tamoxifen injection. 
Interestingly, CAML and TRC40 were also decreased in the knockout line 
(manuscript 2). RNA analysis of these components showed that TRC40 
and CAML transcript levels are unaffected, suggesting that the effect of 
WRB depletion on these components occurs in a post-translational 
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manner. In yeast, the deletion of Get1 or Get2 causes the decrease of the 
second receptor component (Mariappan et al., 2011; Stefer et al., 2011). 
Moreover, Colombo et al. (2016) recently observed that the silencing of 
WRB or CAML causes a reduction in the mRNA and protein levels of the 
other subunit in HeLa cells (Colombo et al., 2016). Nevertheless, a down-
regulation of CAML mRNA upon WRB depletion was not observed in the 
present study in cardiomyocytes or hepatocytes, suggesting that WRB 
might affect CAML protein turnover in those tissues (manuscript 2). 
 
In order to gain insight into the mechanism of TRC40 protein turnover 
upon WRB depletion, experiments with inhibitors of the proteasome 
(oprozomib) and lysosomal function (chloroquine) were carried out in 
HeLa cells. While inhibition of poteasomal protein degradation had no 
effect, the inhibition of lysosomes leaded to the recovery of TRC40 levels 
(manuscript 2). This result suggests that autophagy is involved in the 
clearance of TRC40 in the absence of its receptor. It is worth to highlight 
that these findings are completely in line with results by Colombo et al. 
(2016), where a reduction of TRC40 by depleting CAML and WRB was 
also observed, although the turnover mechanism was not evaluated. It is 
possible to speculate that the degradation of TRC40 might allow the 
recognition and targeting of nascent TA proteins by alternative targeting 
pathways, favouring the their normal membrane insertion. 
 
Taking into account that little is known about the spectrum of substrates 
that depend on TRC40 pathway, the fate of several endogenous TA 
proteins (i.e. syntaxins -5, -6 and -8, emerin and Sec61β) upon depletion 
of the TRC40 receptor was analysed by Western blot and indirect 
immunofluorescence (manuscript 2). Among them, syntaxin-5 (Stx5) 
isoforms (35 kDa and 42 kDa) and emerin (also known as EMD, shown to 
be able to use the TRC40 pathway in manuscript 1) were significantly 
decreased in the WRB knockout animals. Stx5, known as Sed5 in yeast, is 
an essential Qa-SNARE involved in traffic within the Golgi apparatus and 
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between Golgi and the ER (Hardwick and Pelham, 1992; Jahn and 
Scheller, 2006). Early yeast two-hybrid screens identified Sed5 as a 
prominent client of the GET system that requires Get3 and the Get1/Get2 
receptor for its proper biogenesis (Schuldiner et al., 2008). In mammals, 
Norlin et al. (2015) showed that loss of TRC40 in β-cells leads to reduction 
of Stx5 and other TA proteins involved in Golgi-to-ER transport. These 
results show that the dependency of Stx5/Sed5 on the TRC40/GET 
pathway is conserved from yeast to mammals. Our results published in 
manuscript 2 confirm this conservation and highlight that the strong 
dependence on the TRC40 pathway is a unique feature of a small number 
of TA proteins including Stx5/Sed5. 
 
In contrast, the steady state protein levels or the subcellular distribution of 
Sec61β, an auxiliary component of the ER translocon and previously 
considered a model client of the TRC40 pathway based on in vitro 
insertion assays, and Syntaxin 8 (Stx8), a Qc-SNARE in the endosomal 
membrane system and highly expressed in heart (Kasai and Akagawa, 
2001; Subramaniam et al., 2000), were not significantly affected in the 
cardiac WRB knockout line. Moreover, a Qbc SNARE Syntaxin 6 (Stx6), 
involved in vesicular traffic in the trans-Golgi network (Mallard et al., 
2002), presented a change in subcellular localization without alteration of 
steady-state protein levels (manuscript 2). 
 
To further investigate our finding that TRC40 pathway dependence is not a 
general feature of all TA proteins in vivo, a microscopy-based yeast 
screen was carried out in our lab on a larger number of TA proteins. A 
sub-library of 46 N-terminally GFP-Tagged TA proteins was analysed by 
Ákos Farkas and Anne Clancy from the recently generated SWAp-Tag 
library (Yofe et al., 2016) based on the fact that they have human 
homologues (manuscript 2). This approach revealed that only two TA 
proteins, the well characterized Sed5 and Lam5, a protein involved in 
sterol transfer at membrane contact site (Gatta et al., 2015) are severely 
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affected in terms of subcellular localization by deletion of GET system 
components (get3, get1,2 and get1,2,3 knockouts).  
 
Our results in mammalian cells and yeast show that there is no correlation 
between the hydrophobicity of the TA protein TMDs and the dependency 
on TRC40/GET pathways in vivo (manuscript 2), as can be expected from 
previous in-vitro studies with model TA proteins (Favaloro et al., 2010; 
Jonikas et al., 2009; Leznicki et al., 2010; Rabu et al., 2008; Schuldiner et 
al., 2008; Stefanovic and Hegde, 2007). In order to understand the role of 
the TRC40 pathway in the biogenesis of TA proteins, the ER membrane 
insertion of Stx5 and Stx8, one strongly and one less affected substrate 
respectively, was analysed in vitro in TRC40-depleted reticulocyte lysates. 
Interestingly, the insertion of both TA proteins into ER-derived membranes 
was impaired in a considerable but not in a total manner by TRC40 
depletion, suggesting that in this system TRC40 contributes substantially 
but not exclusively to their targeting. Based on these results, we 
hypothesize that alternative pathways/components such as Hsp40/Hsc70 
(Rabu et al., 2008) or the recently described SND components (Aviram et 
al., 2016) might effectively take over the targeting of TA proteins like Stx8 
or Sec61β but not TA proteins like Stx5 once the TRC40 pathway is 
impaired. 
 
The RNA analysis of TA proteins in cardiomyocytes showed that there is 
no effect on the steady-state levels of mRNAs encoding the investigated 
TA proteins in the WRB knockout line (manuscript 2), suggesting that the 
effect on Stx5 or EMD proteins is a consequence of a post-transcriptional 
event, probably a result of an increased in the turnover of those proteins in 
the KO. Experiments with proteasomal and lysosomal inhibitors in HeLa 
cells showed that the knockout of TRC40 or WRB promotes the 
degradation Stx5 in the lysosomes and not in proteasomes. Previous in-
vitro studies have shown that the Bag6 pretargeting complex actively 
mediates the ubiquitylation and subsequent proteasomal degradation of 
 82 
TA proteins (i.e. Sec61β) that fail to engage TRC40 (Hessa et al., 2011). 
Additionally, MSP1, a mitochondrial/peroxisomal AAA-ATPase also 
present in mammals (ATAD1) mediates the clearance of mislocalized tail-
anchored in mitochondria once the GET pathway is impaired, through a 
mechanism that presumably involves the proteasome (Chen et al., 2014; 
Okreglak and Walter, 2014). However, our results with Stx5 in vivo clearly 
demonstrate that not all the TA proteins are targeted to proteasomal 
degradation in the absence of TRC40 or WRB. Considering that Bag6 is 
not present in yeast and that MSP1 is thought to act exclusively at the 
outer mitochondrial membrane and possibly at peroxisomal membranes, 
the existence of an additional clearing mechanism that relies on lysosomal 
degradation is not surprising.  
 
In order to confirm a direct role of autophagy in the degradation of tail 
anchored proteins during their biogenesis, we performed siRNA-mediated 
downregulation in HeLa cells of FAM134B and p62/SQSTM, autophagy 
cargo receptors involved in selective autophagy of ER membrane “ER-
phagy” (Khaminets et al., 2015) or cytosolic aggregates (Pankiv et al., 
2007), respectively (manuscript 2). Down-regulation of FAM134B lead to a 
significant recovery of Stx5 levels in cells where TRC40 was also 
depleted. Previous studies have shown that FAM134B is an evolutionarily 
conserved component that is able to regulate the turnover and structure of 
the ER and possible the Golgi apparatus (Khaminets et al., 2015; Mochida 
et al., 2015). Moreover, the role of FAM134B in ER-phagy relies on two 
features of the protein: a reticulon domain, which promotes membrane 
remodelling, and an LC3-interacting-region (LIR motif) that is able to target 
ER fragments to autophagosomes via LC3-like modifiers.  
 
Because we observed an effect of downregulating ER-phagy on the 
stability of Stx5 in the WRB knockout cells our results suggest that the 
degradation of Stx5 upon TRC40 depletion occurs after its insertion into 
the ER membrane (manuscript 2), implying that alternative pathways 
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might also operate during Stx5 biogenesis in the absence of the TRC40 
system (Fig. 6). However, it is important to highlight that the delivery of 
Stx5 to the ER membrane by TRC40 reduces Stx5 turnover by autophagy, 
suggesting that TRC40 might perform additional roles during Stx5 
biogenesis. For instance, apart from Stx5 TMD shielding, TRC40 might 
prevent Stx5 misfolding in its N-terminal, cytoplasmic domain until delivery 
to the membrane has occurred. 
 
Manuscript 1 provides a fundamental characterization of emerin as a 
TRC40-dependent TA protein client. This information was essential for the 
experiments performed in manuscript 2 where we were able to confirm 
emerin as a TRC40 pathway-dependent TA protein client in vivo. 
Furthermore, the work on emerin allowed us to study TA proteins of the 
inner nuclear membrane. Emerin is an ubiquitous serine-rich highly 
phosphorylated TA protein of the nuclear envelope, tightly associated with 
the nuclear lamina. Mutations of emerin gene (EMD) cause recessive X-
linked Emery-Dreifuss Muscular Dystrophy (EDMD) (Bione et al., 1994), a 
neuromuscular disease characterized by weakening of specific skeletal 
muscles, contractures, cardiomyopathy, and cardiac conduction system 




Figure 6. Model of the Integration of the TRC40 pathway into the cellular 
proteostasis network in vivo. In normal conditions, TRC40 targets nascent 
TA proteins to the WRB/CAML receptor at the ER. In the absence of the 
pathway, although the vast majority of TA proteins can still reach the 
membrane by alternative pathways, a subset of them are degraded by 
autophagy, in a FAM134B-dependent manner.  
 
 
We confirmed that emerin is a client of the TRC40 pathway by in vitro and 
in vivo approaches (manuscript 1). First of all, recombinant emerin and 
TRC40 could be co-purified in a stable complex. Second, the integration of 
emerin in ER-enriched membranes depended on TRC40 and ATP 
presence and could be abolished by the addition of the cytosolic domains 
of WRB and CAML, suggesting that the ER receptor is also involved. 















our WRB KO cardiomyocytes (manuscript 2) demonstrated that the protein 
is affected in terms of localization when the pathway is disrupted. 
 
A subset of EDMD-derived mutations within the region that contains 
emerin TMD was also analyzed. As expected, emerin mutants with drastic 
changes within the TMD localized to the cytosol in HeLa and displayed a 
strong reduction in terms of binding to TRC40 and membrane insertion. 
Interestingly, the Pro183Thr and Pro183His variants presented a 
significant reduction in membrane insertion and were prone to form 
cytoplasmic aggregates, even thought their TMDs are intact. The results 
with the Pro183 mutants are valuable as there are no reports describing 
effects of TA protein cytoplasmic domains on integration efficiency. This 
finding raises the possibility that regions upstream the TA-protein TMD 
could affect the interaction with TRC40. 
 
In collaboration with Janine Pfaff, the targeting of the different emerin 
mutants to the INM was evaluated by two independent approaches: (i) 
differential membrane permeabilization in cells transfected with the 
different mutants and (ii) rapamycin-induced dimerization of an FRB 
domain tagged to the emerin mutants with a nucleoplasmic GFP-tagged 
version of the FKBP12 protein. Both methodologies showed that emerin 
Pro183 mutants and the Phe240His-FS mutant present an impaired 
targeting to the INM, even though these variants can still reach the outer 
nuclear membrane and present similar staining patters as wild type emerin 
when analysed by indirect immunofluorescence (manuscript 1). 
Intriguingly, the insertion efficiency of the Phe240His-FS mutant via the 
TRC40 pathway was markedly low, raising the possibility that the pathway 
affects the correct targeting of emerin to its final destination.  
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Conclusions and perspectives 
This thesis demonstrates a role of the TRC40 system during the insertion 
of emerin, the first described TA protein of the INM that requires the 
pathway. Moreover, the analysis of emerin disease mutants shows that 
there are membrane insertion differences and evidence of mislocalization, 
phenomena that could contribute to the pathological phenotype occurring 
in some EDMD patients. 
 
The thesis also provides evidence for a role of the TRC40 pathway in the 
cellular proteostasis network in vivo. First, I found that the depletion of 
WRB in heart tissue leads to a significant decrease at steady state level of 
other components of the pathway, namely CAML and TRC40. It was 
demonstrated that in the case of TRC40, this reduction is due to an 
increase in its turnover by lysosomal degradation. Unlike a previous report 
in HeLa cells (Colombo et al., 2016), depletion of WRB in heart tissue had 
no effect in the mRNA levels of CAML. However, further studies 
addressing the causes of TRC40 and CAML reduction are required, in 
order to test whether such a reduction allow the targeting of TA proteins by 
alternative pathways/components (e.g. HSP40/HSC70 pathway or SND 
components). Second, I observed that a subset of TA proteins (i.e. Stx5, 
Stx6, emerin) is affected in their steady-state levels and their subcellular 
localization upon WRB knockout in ventricular cardiomyocytes.  
 
It is important to highlight that a correlation between hydrophobicity of TA 
protein TMDs and TRC40 dependency was not observed when comparing 
the steady state levels and subcellular localization of the endogenous TA 
proteins evaluated. These findings in mammalian cells were also 
supported by a microscopic screen in yeast for GET-dependent TA 
proteins carried out by our lab. Based on the low number of TRC40-
dependent TA protein clients identified, it is possible that alternative 
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pathways/components substitute the function of the TRC40 pathway as 
has been previously proposed (Aviram et al., 2016; Rabu et al., 2008), 
thus targeting the majority of TA proteins to the ER membrane. 
Nevertheless, my work delineates TA protein clients such as Stx5 or 
emerin as critically dependent on the TRC40 pathway for their stability and 
correct targeting. Based on these results it will be possible in the future to 
elucidate the relative physiological contributions of different membrane 
protein targeting pathways. 
 
With respect to the integration of the TRC40 pathway into the cellular 
proteostasis network, the work presented in this thesis provides evidence 
of a preponderant role of FAM134B in the clearance of TA proteins by 
selective autophagy once the TRC40-pathway is impaired. Therefore, 
together with Bag6/RNF126 and ATAD1, FAM134B contributes to TA 
protein quality control and cellular proteostasis. However, in the future it 
will be important to clarify the way TA-proteins are recognized and 
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